☰

Jong W. Yu, Ph.D. - Publications

Affiliations: 
2004 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cell Biology
Tree Info Similar researchers PubMed Report error

374 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gao S, Pu N, Yin H, Li J, Chen Q, Yang M, Lou W, Chen Y, Zhou G, Li C, Li G, Yan Z, Liu L, Yu J, Wang X. Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70. Therapeutic Advances in Medical Oncology. 12: 1758835920953728. PMID 32973929 DOI: 10.1177/1758835920953728  0.338
2020 Zhang J, Wong CC, Leung KT, Wu F, Zhou Y, Tong JHM, Chan RCK, Li H, Wang Y, Yan H, Liu L, Wu WKK, Chan MWY, Cheng ASL, Yu J, et al. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential. Oncogene. PMID 32934314 DOI: 10.1038/S41388-020-01458-X  0.375
2020 Li Q, Hu W, Liu WX, Zhao LY, Huang D, Liu XD, Chan H, Zhang Y, Zeng JD, Coker OO, Kang W, Man Ng SS, Zhang L, Wong SH, Gin T, ... ... Yu J, et al. Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting β-galactosidase. Gastroenterology. PMID 32920015 DOI: 10.1053/J.Gastro.2020.09.003  0.335
2020 Li H, Dai W, Xia X, Wang R, Zhao J, Han L, Mo S, Xiang W, Du L, Zhu G, Xie J, Yu J, Liu N, Huang M, Zhu J, et al. Modeling tumor development and metastasis using paired organoids derived from patients with colorectal cancer liver metastases. Journal of Hematology & Oncology. 13: 119. PMID 32883331 DOI: 10.1186/S13045-020-00957-4  0.379
2020 Wei Q, Qian Y, Yu J, Wong CC. Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications. Oncogene. PMID 32839493 DOI: 10.1038/S41388-020-01432-7  0.366
2020 Wang Y, Chen H, Zhang J, Cheng ASL, Yu J, To KF, Kang W. MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication. Biochimica Et Biophysica Acta. Reviews On Cancer. 188415. PMID 32822825 DOI: 10.1016/J.Bbcan.2020.188415  0.388
2020 Wong CC, Xu J, Bian X, Wu JL, Kang W, Qian Y, Li W, Chen H, Gou H, Liu D, Yat Luk ST, Zhou Q, Ji F, Chan LS, Shirasawa S, ... ... Yu J, et al. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. Gastroenterology. PMID 32814111 DOI: 10.1053/J.Gastro.2020.08.016  0.337
2020 Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. PMID 32759302 DOI: 10.1136/Gutjnl-2020-321153  0.338
2020 Wang K, Li E, Busuttil RA, Kong JC, Pattison S, Sung JJY, Yu J, El-Omar EM, Simpson JA, Boussioutas A. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer. Therapeutic Advances in Medical Oncology. 12: 1758835920930359. PMID 32754227 DOI: 10.1177/1758835920930359  0.363
2020 Xia X, Wu WKK, Wong SH, Liu D, Kwong TNY, Nakatsu G, Yan PS, Chuang YM, Chan MW, Coker OO, Chen Z, Yeoh YK, Zhao L, Wang X, Cheng WY, ... ... Yu J, et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 8: 108. PMID 32678024 DOI: 10.1186/S40168-020-00847-4  0.353
2020 Cui M, Liao Q, Li J, Habib JR, Kinny-Köster B, Dong Y, Wolfgang CL, Zhao Y, Yu J. Expression of Cancer-Derived Immunoglobulin G During Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Pilot Study. Pancreas. 49: e51-e54. PMID 32590623 DOI: 10.1097/Mpa.0000000000001572  0.327
2020 Coker OO, Kai Wu WK, Wong SH, Sung JJ, Yu J. Altered Gut Archaea Composition and Interaction with Bacteria are Associated with Colorectal Cancer. Gastroenterology. PMID 32569776 DOI: 10.1053/J.Gastro.2020.06.042  0.345
2020 Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. PMID 32514151 DOI: 10.1038/S41388-020-1341-1  0.312
2020 Zhao R, Coker OO, Wu J, Zhou Y, Zhao L, Nakatsu G, Bian X, Wei H, Chan AW, Sung JJ, Chan FK, El-Omar E, Yu J. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects. Gastroenterology. PMID 32387495 DOI: 10.1053/J.Gastro.2020.05.004  0.322
2020 Zhou Y, Zhang J, Li H, Huang T, Wong CC, Wu F, Wu M, Weng N, Liu L, Cheng ASL, Yu J, Wong N, Lo KW, Tang PMK, Kang W, et al. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis. Oncogene. PMID 32313226 DOI: 10.1038/S41388-020-1293-5  0.352
2020 Zhang J, Huang JZ, Zhang YQ, Zhang X, Zhao LY, Li CG, Zhou YF, Wei H, Yu J. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. Ebiomedicine. 53: 102701. PMID 32151798 DOI: 10.1016/J.Ebiom.2020.102701  0.307
2020 Zhao Y, Zhang J, Cheng ASL, Yu J, To KF, Kang W. Gastric cancer: genome damaged by bugs. Oncogene. PMID 32123313 DOI: 10.1038/S41388-020-1241-4  0.371
2020 Mo S, Zhang L, Dai W, Han L, Wang R, Xiang W, Wang Z, Li Q, Yu J, Yuan J, Cai S, Cai G. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer. Cell Death & Disease. 11: 155. PMID 32111819 DOI: 10.1038/S41419-020-2338-Y  0.355
2020 Lau HCH, Kranenburg O, Xiao H, Yu J. Organoid models of gastrointestinal cancers in basic and translational research. Nature Reviews. Gastroenterology & Hepatology. PMID 32099092 DOI: 10.1038/S41575-019-0255-2  0.372
2020 Yeoh YK, Chen Z, Wong MCS, Hui M, Yu J, Ng SC, Sung JJY, Chan FKL, Chan PKS. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor. Gut. PMID 32051205 DOI: 10.1136/Gutjnl-2019-319635  0.319
2020 Sung JJY, Coker OO, Chu E, Szeto CH, Luk STY, Lau HCH, Yu J. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after eradication. Gut. PMID 31974133 DOI: 10.1136/Gutjnl-2019-319826  0.306
2020 Polytarchou C, Hatziapostolou M, Koutsioumpa M, Christodoulou N, Yau TO, Birli E, Pomenya O, Montiel-Duarte C, Joshi SM, Hommes DW, Verspaget HW, Yu J, Iliopoulos D. Abstract LB-184: A lncRNA-histone acetyltransferase complex induces colorectal oncogenesis through regulation of a metabolic kinase network Cancer Research. 80. DOI: 10.1158/1538-7445.Am2020-Lb-184  0.366
2020 Gou H, Su H, Wang X, Chen H, Zhai J, Liu W, Liang JQ, Sung JJ, Fang J, Yu J. Sa1172 TRIP6-DEPENDENT ACTIVATION OF AKT/HIF1A CASCADE PROMOTES COLORECTAL CANCER METASTASIS BY DISRUPTING THE INTEGRITY OF CELL TIGHT JUNCTIONS Gastroenterology. 158: S-299. DOI: 10.1016/S0016-5085(20)31444-X  0.363
2020 Wolfgang CL, Ding D, Hasanain A, Oosten FV, Gemenetzis G, Groot V, Tenior J, Javed AA, Wright M, Yu J, Cameron J, Weiss M, Burns WR, Burkhart R, Zheng L, et al. Persistent Circulating Tumor Cells At One Year After Oncologic Resection Of Pancreatic Cancer Predict Recurrence Hpb. 22. DOI: 10.1016/J.Hpb.2020.04.785  0.327
2019 Ng C, Li H, Wu WKK, Wong SH, Yu J. Genomics and metagenomics of colorectal cancer. Journal of Gastrointestinal Oncology. 10: 1164-1170. PMID 31949936 DOI: 10.21037/Jgo.2019.06.04  0.355
2019 Pu N, Chen Q, Gao S, Liu G, Zhu Y, Yin L, Hu H, Wei L, Wu Y, Maeda S, Lou W, Yu J, Wu W. Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. Annals of Translational Medicine. 7: 645. PMID 31930046 DOI: 10.21037/Atm.2019.10.91  0.348
2019 Li H, Zhang J, Tong JHM, Chan AWH, Yu J, Kang W, To KF. Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors. International Journal of Molecular Sciences. 20. PMID 31795192 DOI: 10.3390/Ijms20235999  0.339
2019 Liang JQ, Li T, Nakatsu G, Chen YX, Yau TO, Chu E, Wong S, Szeto CH, Ng SC, Chan FKL, Fang JY, Sung JJY, Yu J. A novel faecal marker for the non-invasive diagnosis of colorectal adenoma and cancer. Gut. PMID 31776231 DOI: 10.1136/Gutjnl-2019-318532  0.344
2019 Wang S, Huang J, Li C, Zhao L, Wong CC, Zhai J, Zhou Y, Deng W, Zeng Y, Gao S, Zhang Y, Wang G, Guan XY, Wei H, Wong SH, ... ... Yu J, et al. MAP9 loss triggers chromosomal instability, initiates colorectal tumorigenesis and is associated with poor survival of colorectal cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31662330 DOI: 10.1158/1078-0432.Ccr-19-1611  0.312
2019 Li T, Li B, Sara A, Ay C, Leung WY, Zhang Y, Dong Y, Liang Q, Zhang X, Weidner P, Gutting T, Behrens HM, Röcken C, Sung JJ, Ebert MP, ... Yu J, et al. Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer. Oncoimmunology. 8: e1649961. PMID 31646096 DOI: 10.1080/2162402X.2019.1649961  0.377
2019 Dong Y, Zhang Y, Kang W, Wang G, Chen H, Higashimori A, Nakatsu G, Go M, Tong JH, Zheng S, To KF, Sung JJ, Yang X, Ng SS, Yu J. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6. Theranostics. 9: 6517-6531. PMID 31588233 DOI: 10.7150/Thno.34989  0.376
2019 Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nature Reviews. Gastroenterology & Hepatology. PMID 31554963 DOI: 10.1038/S41575-019-0209-8  0.342
2019 Wong CC, Kang W, Xu J, Qian Y, Luk STY, Chen H, Li W, Zhao L, Zhang X, Chiu PW, Ng EK, Yu J. Prostaglandin E induces DNA hypermethylation in gastric cancer and . Theranostics. 9: 6256-6268. PMID 31534549 DOI: 10.7150/Thno.35766  0.353
2019 Long X, Wong CC, Tong L, Chu ESH, Ho Szeto C, Go MYY, Coker OO, Chan AWH, Chan FKL, Sung JJY, Yu J. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nature Microbiology. PMID 31501538 DOI: 10.1038/S41564-019-0541-3  0.328
2019 Zhang J, Tang PMK, Zhou Y, Cheng ASL, Yu J, Kang W, To KF. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis. Cells. 8. PMID 31242658 DOI: 10.3390/Cells8060637  0.356
2019 Yu J, Wang S, Zhang Y, Huang J, Wong CC, Zhai J, Li C, Wei G, Zhao L, Wang G, Wei H, Zhao Z. TRIM67 activates p53 to suppress colorectal cancer initiation and progression. Cancer Research. PMID 31239268 DOI: 10.1158/0008-5472.Can-18-3614  0.345
2019 Wong KC, Chen J, Zhang J, Lin J, Yan S, Zhang S, Li X, Liang C, Peng C, Lin Q, Kwong S, Yu J. Early Cancer Detection from Multianalyte Blood Test Results. Iscience. 15: 332-341. PMID 31103852 DOI: 10.1016/J.Isci.2019.04.035  0.328
2019 Xing R, Zhou Y, Yu J, Yu Y, Nie Y, Luo W, Yang C, Xiong T, Wu WKK, Li Z, Bing Y, Lin S, Zhang Y, Hu Y, Li L, et al. Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer. Nature Communications. 10: 2037. PMID 31048690 DOI: 10.1038/S41467-019-09644-6  0.364
2019 Yu J, Sung JJ. Differential colorectal cancer genomics between east and west. Journal of Gastroenterology and Hepatology. 34: 811-812. PMID 31044476 DOI: 10.1111/Jgh.14675  0.33
2019 Groot VP, Blair AB, Gemenetzis G, Ding D, Burkhart RA, Yu J, Borel Rinkes IHM, Molenaar IQ, Cameron JL, Weiss MJ, Wolfgang CL, He J. Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 31023560 DOI: 10.1016/J.Ejso.2019.04.007  0.304
2019 Gou H, Liang JQ, Zhang L, Chen H, Zhang Y, Li R, Wang X, Ji J, Tong JH, To KF, Sung JJ, Chan FK, Fang JY, Yu J. TTPAL promotes colorectal tumorigenesis by stabilizing TRIP6 to activate Wnt/β-catenin signaling. Cancer Research. PMID 31018940 DOI: 10.1158/0008-5472.Can-18-2986  0.344
2019 Zhang J, Zhou Y, Tang PMK, Cheng ASL, Yu J, To KF, Kang W. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis. International Journal of Molecular Sciences. 20. PMID 30934860 DOI: 10.3390/Ijms20071576  0.361
2019 Wang X, Wu WKK, Gao J, Li Z, Dong B, Lin X, Li Y, Li Y, Gong J, Qi C, Peng Z, Yu J, Shen L. Autophagy inhibition enhances PD-L1 expression in gastric cancer. Journal of Experimental & Clinical Cancer Research : Cr. 38: 140. PMID 30925913 DOI: 10.1186/S13046-019-1148-5  0.308
2019 Yue GG, Li L, Lee JK, Kwok HF, Wong EC, Li M, Fung KP, Yu J, Chan AW, Chiu PW, Lau CB. Multiple modulatory activities of Andrographis paniculata on immune responses and xenograft growth in esophageal cancer preclinical models. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 152886. PMID 30910259 DOI: 10.1016/J.Phymed.2019.152886  0.374
2019 Zhang L, Li W, Cao L, Xu J, Qian Y, Chen H, Zhang Y, Kang W, Gou H, Wong CC, Yu J. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53. Oncogene. PMID 30745575 DOI: 10.1038/S41388-019-0743-4  0.422
2019 Wang X, Liang JQ, Zhang LH, Gou H, Li Z, Chen H, Dong Y, Ji J, Yu J. C8orf76 promotes gastric tumorigenicity and metastasis by directly inducing lncRNA DUSP5P1 and associates with patient outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30733230 DOI: 10.1158/1078-0432.Ccr-18-2804  0.357
2019 Skaro M, Nanda N, Gauthier C, Felsenstein M, Jiang Z, Qiu M, Shindo K, Yu J, Hutchings D, Javed AA, Beckman R, He J, Wolfgang CL, Thompson E, Hruban RH, et al. Prevalence of Germline Mutations Associated with Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. Gastroenterology. PMID 30716324 DOI: 10.1053/J.Gastro.2019.01.254  0.312
2019 Yu J, Zhao L, Zhao R, Long X, Coker OO, Sung JJY. The role of Parvimonas micra in intestinal tumorigenesis in germ-free and conventional APCmin/+ mice. Journal of Clinical Oncology. 37: 531-531. DOI: 10.1200/Jco.2019.37.4_Suppl.531  0.321
2019 Yun Q, Wong CC, Yu J. IDDF2019-ABS-0203 SCNN1B Functions as a tumor suppressor in colorectal cancer by inhibiting RAS-RAF-MEK-ERK pathway Gut. 68. DOI: 10.1136/Gutjnl-2019-Iddfabstracts.38  0.358
2019 Cheng B, Meng X, Yu J. A nomogram to predict outcomes of lung cancer patients after pneumonectomy based on 47 indicators set by principle component analysis Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz259.005  0.304
2019 Liu X-, Song G, Jiang H, Di L-, Yu J, Jia S, Li H, Liang X. Peripheral cytotoxic T cell correlates with tumor mutational burden and is predictive for progression free survival in advanced breast cancer Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz239.060  0.32
2019 Liang JQ, Wong SH, Szeto CH, Chu ES, Lau HC, Yu J, Sung JJ. Su1657 – Fecal Microbial Markers in Colorectal Cancer Screening for Symptomatic and Asymptomatic Subjects Gastroenterology. 156: S-600. DOI: 10.1016/S0016-5085(19)38395-7  0.302
2019 Shi H, Cheng WY, Huang S, Xu W, Yu J, Wang J. Su1071 – Novel Long Non-Coding Rna Molecular Subtypes of Gastric Cancer and the Clinical Implication Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)38124-7  0.318
2019 Liang JQ, Yau TO, Yau TCD, Szeto CH, Zhao FS, Chan FK, Sung JJ, Yu J. Su1052 – A Novel Microrna Panel for Non-Invasive Diagnosis and Prognosis of Colorectal Cancer Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)38106-5  0.342
2019 Wong CC, Xu J, Li W, Kang W, To KF, Sung JJ, Yu J. Sa2009 – Combinatorial Blockade of De Novo Cholesterol Biosynthesis and Pcsk9 As a Synergistic Therapy Fro KrasMutant Colorectal Cancer Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)38032-1  0.302
2019 Wong CC, Xu J, Li W, Qian Y, Kang W, Wu J, Sung JJ, Yu J. 855 – Slc25A22 Drives Oncometabolite Succinate to Promote Wnt/Β-Catenin Signaling and Cancer Stemness in Kras-Mutant Colorectal Cancer Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)37264-6  0.33
2019 Zhao R, Coker OO, Wu J, Zhao L, Nakatsu D, Bian X, Sung JJ, Chan FK, El-Omar EM, Yu J. 630 – Gut Microbiota Modulates the Chemopreventive Efficacy of Aspirin on Colon Cancer Through Reducing Aspirin Bioavailability Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)37121-5  0.326
2019 GAO S, Soares F, Wang S, Chen H, Ahmed M, Sung JJ, He HH, Yu J. 451 – Functional Genomic Screening Using Crispr/Cas9 Identifies Mevalonate Pathway As Essential for Colon Cancer Stem Cells-Enriched Tumorspheroids Gastroenterology. 156: S-95. DOI: 10.1016/S0016-5085(19)37024-6  0.314
2019 Peng L, Xing R, Liu D, Bao L, Cheng W, Wang H, Yu Y, Liu X, Jiang L, Wu Y, An Z, Liang Q, Kim RN, Shin YK, Yang H, ... Yu J, et al. Characterization and validation of somatic mutation spectrum to reveal heterogeneity in gastric cancer by single cell sequencing Science Bulletin. 64: 236-244. DOI: 10.1016/J.Scib.2018.12.014  0.336
2018 Zhang J, Cheng ASL, Yu J, To KF, Kang W. Targeting the miR-630/YAP1/ERK feedback loop in epidermal growth factor receptor-mutated lung adenocarcinomas. Journal of Thoracic Disease. 10: S4017-S4020. PMID 30631543 DOI: 10.21037/Jtd.2018.10.16  0.304
2018 Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, Chan FKL, Sung JJY, Yu J. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. PMID 30472682 DOI: 10.1136/Gutjnl-2018-317178  0.347
2018 Luchini C, Pea A, Yu J, He J, Salvia R, Riva G, Weiss MJ, Bassi C, Cameron JL, Hruban RH, Goggins M, Wolfgang CL, Scarpa A, Wood LD, Lawlor RT. Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 30467323 DOI: 10.1038/S41379-018-0183-7  0.323
2018 Wang X, Li X, Zhang L, Wong SH, Wang MHT, Tse G, Dai RZW, Nakatsu G, Coker OO, Chen Z, Ko H, Chan JYK, Liu T, Cheng CHK, Cheng ASL, ... Yu J, et al. Oncogenes expand during evolution to withstand somatic amplification. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30204835 DOI: 10.1093/Annonc/Mdy397  0.312
2018 Pan Y, Tong JHM, Kang W, Lung RWM, Chak WP, Chung LY, Wu F, Li H, Yu J, Chan AWH, To KF. EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer. Molecular Carcinogenesis. PMID 30155936 DOI: 10.1002/Mc.22896  0.365
2018 Zhang J, Zhou Y, Huang T, Wu F, Pan Y, Dong Y, Wang Y, Chan AKY, Liu L, Kwan JSH, Cheung AHK, Wong CC, Lo AKF, Cheng ASL, Yu J, et al. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. Oncogene. PMID 30082912 DOI: 10.1038/S41388-018-0430-X  0.363
2018 Li W, Wong CC, Zhang X, Kang W, Nakatsu G, Zhao Q, Chen H, Go MYY, Chiu PWY, Wang X, Ji J, Li X, Cai Z, Ng EKW, Yu J. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis. Oncogene. PMID 30054562 DOI: 10.1038/S41388-018-0402-1  0.372
2018 Pan Y, Tong JHM, Lung RWM, Kang W, Kwan JSH, Chak WP, Tin KY, Chung LY, Wu F, Ng SSM, Mak TWC, Yu J, Lo KW, Chan AWH, To KF. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. Molecular Cancer. 17: 102. PMID 30037330 DOI: 10.1186/S12943-018-0853-6  0.364
2018 Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Journal of Experimental & Clinical Cancer Research : Cr. 37: 130. PMID 29970191 DOI: 10.1186/S13046-018-0807-2  0.314
2018 Li W, Ng JM, Wong CC, Ng EKW, Yu J. Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer. Oncogene. PMID 29795331 DOI: 10.1038/S41388-018-0341-X  0.391
2018 Wong SH, Kwong TNY, Wu CY, Yu J. Clinical applications of gut microbiota in cancer biology. Seminars in Cancer Biology. PMID 29782923 DOI: 10.1016/J.Semcancer.2018.05.003  0.359
2018 Kwong TNY, Wang X, Nakatsu G, Chow TC, Tipoe T, Dai RZW, Tsoi KKK, Wong MCS, Tse G, Chan MTV, Chan FKL, Ng SC, Wu JCY, Wu WKK, Yu J, et al. Association Between Bacteremia from Specific Microbes and Subsequent Diagnosis of Colorectal Cancer. Gastroenterology. PMID 29729257 DOI: 10.1053/J.Gastro.2018.04.028  0.346
2018 Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein & Cell. PMID 29713943 DOI: 10.1007/S13238-018-0543-6  0.337
2018 Nakatsu G, Zhou H, Wu WKK, Wong SH, Coker OO, Dai Z, Li X, Szeto CH, Sugimura N, Yuen-Tung Lam T, Chi-Shing Yu A, Wang X, Chen Z, Chi-Sang Wong M, Ng SC, ... ... Yu J, et al. Alterations in Enteric Virome Associate With Colorectal Cancer and Survival Outcomes. Gastroenterology. PMID 29689266 DOI: 10.1053/J.Gastro.2018.04.018  0.335
2018 Zhang J, Zhou Y, Huang T, Wu F, Liu L, Kwan JSH, Cheng ASL, Yu J, To KF, Kang W. PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis. Molecular Carcinogenesis. PMID 29683214 DOI: 10.1002/Mc.22831  0.384
2018 Tamura K, Yu J, Hata T, Suenaga M, Shindo K, Abe T, MacGregor-Das A, Borges M, Wolfgang CL, Weiss MJ, He J, Canto MI, Petersen GM, Gallinger S, Syngal S, et al. Mutations in the pancreatic secretory enzymes and are associated with pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 29669919 DOI: 10.1073/Pnas.1720588115  0.321
2018 Wong CC, Li W, Chan B, Yu J. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Seminars in Cancer Biology. PMID 29665409 DOI: 10.1016/J.Semcancer.2018.04.002  0.348
2018 Huang T, Zhou Y, Zhang J, Cheng ASL, Yu J, To KF, Kang W. The physiological role of Motin family and its dysregulation in tumorigenesis. Journal of Translational Medicine. 16: 98. PMID 29650031 DOI: 10.1186/S12967-018-1466-Y  0.357
2018 Dai Z, Coker OO, Nakatsu G, Wu WKK, Zhao L, Chen Z, Chan FKL, Kristiansen K, Sung JJY, Wong SH, Yu J. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 6: 70. PMID 29642940 DOI: 10.1186/S40168-018-0451-2  0.314
2018 Cao L, Wang S, Zhang Y, Wong KC, Nakatsu G, Wang X, Wong S, Ji J, Yu J. Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A. Oncogene. PMID 29610526 DOI: 10.1038/S41388-018-0220-5  0.421
2018 Gemenetzis G, Groot VP, Blair AB, Laheru DA, Zheng L, Narang AK, Fishman EK, Hruban RH, Yu J, Burkhart RA, Cameron JL, Weiss MJ, Wolfgang CL, He J. Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. Annals of Surgery. PMID 29596120 DOI: 10.1097/Sla.0000000000002753  0.302
2018 Li L, Yue GG, Lee JK, Wong EC, Fung KP, Yu J, Lau CB, Chiu PW. Gene expression profiling reveals the plausible mechanisms underlying the antitumor and antimetastasis effects of Andrographis paniculata in esophageal cancer. Phytotherapy Research : Ptr. PMID 29577460 DOI: 10.1002/Ptr.6074  0.333
2018 Zhang Y, Wang S, Kang W, Liu C, Dong Y, Ren F, Wang Y, Zhang J, Wang G, To KF, Zhang X, Sung JJ, Chang Z, Yu J. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation. Oncogene. PMID 29563608 DOI: 10.1038/S41388-018-0161-Z  0.349
2018 Tang J, Chen H, Wong CC, Liu D, Li T, Wang X, Ji J, Sung JJ, Fang JY, Yu J. DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients. Oncogene. PMID 29535419 DOI: 10.1038/S41388-018-0196-1  0.357
2018 Zhang L, Zhang Y, Wong SH, Law PTY, Zhao S, Yu J, Chan MTV, Wu WKK. Common Deregulation of Seven Biological Processes by MicroRNAs in Gastrointestinal Cancers. Scientific Reports. 8: 3287. PMID 29459716 DOI: 10.1038/S41598-018-21573-W  0.357
2018 Liu L, Zhang Y, Wong CC, Zhang J, Dong Y, Li X, Kang W, Chan FK, Sung JJ, Yu J. RNF6 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of TLE3. Cancer Research. PMID 29374067 DOI: 10.1158/0008-5472.Can-17-2683  0.373
2018 Higashimori A, Dong Y, Zhang Y, Kang W, Nakatsu G, Ng SS, Arakawa T, Sung JJ, Chan FK, Yu J. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-β-catenin signaling axis. Cancer Research. PMID 29374064 DOI: 10.1158/0008-5472.Can-17-2403  0.384
2018 Zhang L, Hu W, Cho CH, Chan FKL, Yu J, Ross Fitzgerald J, Cheung CKY, Xiao ZG, Shen J, Li LF, Li MX, Wu JCY, Ling TKW, Chan JYK, Ho K, et al. Reduced lysosomal clearance of autophagosomes promotes survival and colonization of Helicobacter pylori. The Journal of Pathology. PMID 29327342 DOI: 10.1002/Path.5033  0.312
2018 Wang K, Li EX, Busuttil RA, Kong JC, Pattison ST, Sung JJY, Yu J, El-Omar EM, Simpson JA, Boussioutas A. Differential response to adjuvant chemotherapy based on Lauren subtype affects clinical outcome of gastric cancer: A cohort study and meta-analysis. Journal of Clinical Oncology. 36: 4048-4048. DOI: 10.1200/Jco.2018.36.15_Suppl.4048  0.372
2018 Lin R, Fan N, Li H, Liu J, Zhao S, Yu J. Apatinib reverses resistance of paclitaxel-containing regimens in advanced gastric cancer: A phase II study. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy432.021  0.325
2018 Dai Z, Coker OO, Nakatsu G, Wu WK, Zhao L, Chen Z, Chan FK, Kristiansen K, Sung JJ, Wong SH, Yu J. Tu1885 - Multi-Cohort Analysis of Colorectal Cancer Metagenome Identified Altered Bacteria Across Populations and Universal Bacterial Markers Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33511-X  0.32
2018 Wang X, Liang Q, Zhang L, Sung JJ, Ji J, Yu J. Su1241 - C8ORF76 Functions as a Novel Oncogene via Directly Regulating Lncrna DUSP5P1 in Gastric Cancer Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)31941-3  0.381
2018 Li W, Wong CC, Kang W, Nakatsu D, Chen H, Chiu PWYW, Ng EK, Yu J. Su1226 - Cab39L Elicited an Anti-Warburg Effect via a Lkb1-Ampk-Pgc1α Axis to Inhibit Gastric Tumorigenesis Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)31926-7  0.307
2018 Nakatsu G, Zhou H, Wu WK, Wong SH, Coker OO, Dai Z, Li X, Yu AC, Wang X, Chen Z, Chan MT, Chan PK, Chan FK, Sung JJ, Yu J. 150 - Alterations of the Enteric Virome in Colorectal Cancer Gastroenterology. 154: S-41. DOI: 10.1016/S0016-5085(18)30608-5  0.357
2018 Long X, Li T, Chu ES, Chan FK, Yu J. 148 - Functional Investigation of a Novel Oncogenic Bacterium Peptostreptococcus Anaerobius in Colorectal Carcinogenesis Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)30606-1  0.304
2018 Coker OO, Nakatsu G, Dai Z, Wu WK, Wong SH, Chan FK, Sung JJ, Yu J. 87 - Enteric Fungi Compositional and Ecological Dysbiosis in Colorectal Cancer Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)30563-8  0.336
2017 Lam SY, Yu J, Wong SH, Peppelenbosch MP, Fuhler GM. The gastrointestinal microbiota and its role in oncogenesis. Best Practice & Research. Clinical Gastroenterology. 31: 607-618. PMID 29566903 DOI: 10.1016/J.Bpg.2017.09.010  0.356
2017 Sun W, Zhang Y, Wong KC, Liu K, Yang Y, Wu B, Tong JH, Chan AW, Chan HL, Yu J. Increased expression of GATA Zinc Finger Domain Containing 1 via gene amplification promotes liver cancer by directly inducing PRL3. Hepatology (Baltimore, Md.). PMID 29266303 DOI: 10.1002/Hep.29750  0.33
2017 Huang T, Zhou Y, Zhang J, Wong CC, Li W, Kwan JSH, Yang R, Chan AKY, Dong Y, Wu F, Zhang B, Cheung AHK, Wu WKK, Cheng ASL, Yu J, et al. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis. Oncogene. PMID 29234151 DOI: 10.1038/S41388-017-0029-7  0.315
2017 Mommersteeg MC, Yu J, Peppelenbosch MP, Fuhler GM. Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms. Biochimica Et Biophysica Acta. PMID 29154808 DOI: 10.1016/J.Bbcan.2017.11.003  0.339
2017 Ayars M, O'Sullivan E, Macgregor-Das A, Shindo K, Kim H, Borges M, Yu J, Hruban RH, Goggins M. IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth. Oncotarget. 8: 83370-83383. PMID 29137350 DOI: 10.18632/Oncotarget.19848  0.343
2017 Brim H, Yooseph S, Lee E, Sherif Z, Abbas M, Laiyemo AO, Varma S, Torralba M, Dowd SE, Nelson KE, Pathmasiri W, Sumner S, de Vos W, Liang Q, Yu J, et al. A Microbiomic Analysis in African Americans with Colonic Lesions Reveals Streptococcus sp.VT162 as a Marker of Neoplastic Transformation. Genes. 8. PMID 29120399 DOI: 10.3390/Genes8110314  0.339
2017 Liu L, Wong CC, Gong B, Yu J. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer. Oncogene. PMID 28925398 DOI: 10.1038/Onc.2017.313  0.346
2017 Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Tamura K, Almario JAN, Brant A, Borges M, Siddiqui A, Datta L, Wolfgang CL, Hruban RH, Klein AP, Goggins M. Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer. Oncotarget. 8: 50824-50831. PMID 28881607 DOI: 10.18632/Oncotarget.15137  0.301
2017 Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, Xiao X, Kwong TN, Tsoi H, Wu WK, Benhua Z, Chan FK, Sung JJ, Wei H, Yu J. Gavage of Fecal Samples From Patients with Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-free and Conventional Mice. Gastroenterology. PMID 28823860 DOI: 10.1053/J.Gastro.2017.08.022  0.35
2017 Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, Macgregor-Das A, Siddiqui A, Witmer PD, Tamura K, Song TJ, Navarro Almario JA, Brant A, Borges M, Ford M, Barkley T, et al. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017723502. PMID 28767289 DOI: 10.1200/Jco.2017.72.3502  0.327
2017 Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, Wu WK, Wong SH, Chen Z, Sung JJY, Yu J. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. PMID 28765474 DOI: 10.1136/Gutjnl-2017-314281  0.31
2017 Tsoi H, Lam KC, Dong Y, Zhang X, Lee CK, Zhang J, Ng SC, Ng SSM, Zheng S, Chen Y, Fang J, Yu J. Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients. Oncogene. PMID 28692053 DOI: 10.1038/Onc.2017.86  0.39
2017 Li L, Yue GG, Lee JK, Wong EC, Fung KP, Yu J, Lau CB, Chiu PW. The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives. Scientific Reports. 7: 854. PMID 28405006 DOI: 10.1038/S41598-017-00934-X  0.35
2017 Zhou Y, Huang T, Siu HL, Wong CC, Dong Y, Wu F, Zhang B, Wu WK, Cheng AS, Yu J, To KF, Kang W. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. Molecular Cancer. 16: 77. PMID 28399871 DOI: 10.1186/S12943-017-0647-2  0.371
2017 Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang Y, Zhou J, Pan K, Sun L, Fang J, Yuan Y, You W, Fan D. A global burden of gastric cancer: the major impact of China. Expert Review of Gastroenterology & Hepatology. PMID 28351219 DOI: 10.1080/17474124.2017.1312342  0.358
2017 Zhang L, Zhou Y, Huang T, Cheng AS, Yu J, Kang W, To KF. The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric Carcinogenesis. International Journal of Molecular Sciences. 18. PMID 28230721 DOI: 10.3390/Ijms18020450  0.335
2017 Yu J, Yun Q, Wong CC, Xu J, Chen H, Zhang Y, Kang W, Wang H, Zhang L, Li W, Chu ES, Go MY, Chiu PW, Ng EK, Chan FK, et al. Sodium channel subunit SCNN1B suppresses gastric cancer growth and metastasis via GRP78 degradation. Cancer Research. PMID 28202509 DOI: 10.1158/0008-5472.Can-16-1595  0.41
2017 Tsoi H, Chu ES, Zhang X, Sheng J, Nakatsu D, Ng SC, Chan AW, Chan FK, Sung JJ, Yu J. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. PMID 28126350 DOI: 10.1053/J.Gastro.2017.01.009  0.356
2017 Wong CC, Qian Y, Yu J. Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches. Oncogene. PMID 28092669 DOI: 10.1038/Onc.2016.485  0.304
2017 Wu WK, Li X, Wang X, Dai RZ, Cheng AS, Wang MH, Kwong T, Chow TC, Yu J, Chan MT, Wong SH. Oncogenes without a neighboring tumor-suppressor gene are more prone to amplification. Molecular Biology and Evolution. PMID 28087780 DOI: 10.1093/Molbev/Msw295  0.343
2017 Liang JQ, Xu F, Zheng S, Yu J. Abstract 5519: psiTPTE22-HERV functions as a tumor suppressor in gastric cancer and is associated with disease outcome Cancer Research. 77: 5519-5519. DOI: 10.1158/1538-7445.Am2017-5519  0.353
2017 Feng J, Shen B, He Z, Deng L, Dai A, Shen X, Chen L, Jiang H, Li X, Zhou G, Yu J, Yang L, Chen P, Zhuang M. 695PReal world data about clinical efficacy and safety of apatinib in the treatment of advanced gastric cancer Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx369.079  0.322
2017 Wong SH, Zhao L, Zhang X, Xu W, Xiao X, Kwong T, Wu WK, Zeng B, Sung JJ, Wei H, Yu J. Stools from Colorectal Cancer Patients Promote Intestinal Carcinogenesis in Animal Models Through Inducing Th17-Mediated Inflammation Gastroenterology. 152: S1011. DOI: 10.1016/S0016-5085(17)33429-7  0.346
2017 Cao L, Wang S, Zhang Y, Wong KC, Nakatsu D, Sung JJ, Yu J. Zinc-Finger Protein 471 Functions as a Tumor Suppressor in Gastric Cancer through Transcriptionally Repressing TFAP2A and PLS3 Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)32771-3  0.368
2017 Liu L, Zhang Y, Zhang J, Dong YJ, Chan FK, Yu J. Ring Finger Protein 6 Exerts an Oncogenic Role in Colorectal Cancer by Activating WNT/β-Catenin Pathway Through TLE3 Ubiquitin Degradation Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)30835-1  0.316
2017 Zhao L, Zhang X, Zuo T, Yu J. The Composition of Colonic Commensal Bacteria According to Anatomical Localization in Colorectal Cancer Engineering. 3: 90-97. DOI: 10.1016/J.Eng.2017.01.012  0.324
2016 Huang T, Zhou Y, Cheng AS, Yu J, To KF, Kang W. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors? Molecular Cancer. 15: 80. PMID 27938406 DOI: 10.1186/S12943-016-0566-7  0.399
2016 Wong SH, Kwong TN, Chow TC, Luk AK, Dai RZ, Nakatsu G, Lam TY, Zhang L, Wu JC, Chan FK, Ng SS, Wong MC, Ng SC, Wu WK, Yu J, et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut. PMID 27797940 DOI: 10.1136/Gutjnl-2016-312766  0.315
2016 Liang JQ, Chiu J, Chen Y, Huang Y, Higashimori A, Fang JY, Brim H, Ashktorab H, Ng SC, Ng SS, Zheng S, Chan FK, Sung JJ, Yu J. Fecal Bacteria Act as Novel Biomarkers for Non-Invasive Diagnosis of Colorectal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27697996 DOI: 10.1158/1078-0432.Ccr-16-1599  0.345
2016 Wong CC, Qian Y, Li X, Xu J, Kang W, Tong JH, To KF, Jin Y, Li W, Chen H, Go MY, Wu JL, Cheng KW, Ng SS, Sung JJ, ... ... Yu J, et al. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations, and Xenograft Tumor Progression in Mice, via Intracellular Synthesis of Aspartate. Gastroenterology. PMID 27451147 DOI: 10.1053/J.Gastro.2016.07.011  0.351
2016 Yu J, Liang Q, Wang J, Wang K, Gao J, Zhang J, Zeng Y, Chiu PW, Ng EK, Sung JJ. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene. PMID 27212034 DOI: 10.1038/Onc.2016.187  0.389
2016 Wu WK, Yu J, Chan MT, To KF, Cheng AS. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumorigenesis. The Journal of Pathology. PMID 27102722 DOI: 10.1002/Path.4731  0.367
2016 Tang S, Wu WK, Li X, Wong SH, Wong N, Chan MT, Sung JJ, Yu J. Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression. Scientific Reports. 6: 24466. PMID 27080237 DOI: 10.1038/Srep24466  0.344
2016 Han F, Sun LP, Liu S, Xu Q, Liang QY, Zhang Z, Cao HC, Yu J, Fan DM, Nie YZ, Wu KC, Yuan Y. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis. Oncotarget. PMID 27050149 DOI: 10.18632/Oncotarget.8523  0.312
2016 Li X, Wu WK, Xing R, Wong SH, Liu Y, Fang X, Zhang Y, Wang M, Wang J, Li L, Zhou Y, Tang S, Peng S, Qiu K, Chen L, ... ... Yu J, et al. Distinct subtypes of gastric cancer defined by molecular characterization include novel mutational signatures with prognostic capability. Cancer Research. PMID 26857262 DOI: 10.1158/0008-5472.Can-15-2443  0.374
2016 Kang W, Cheng AS, Yu J, To KF. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers. World Journal of Gastroenterology. 22: 1279-88. PMID 26811664 DOI: 10.3748/Wjg.V22.I3.1279  0.373
2016 Zhou Y, Huang T, Cheng AS, Yu J, Kang W, To KF. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis. International Journal of Molecular Sciences. 17. PMID 26805820 DOI: 10.3390/Ijms17010138  0.355
2016 Huang T, Kang W, Zhang B, Wu F, Dong Y, Tong JH, Yang W, Zhou Y, Zhang L, Cheng AS, Yu J, To KF. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis. Molecular Cancer. 15: 9. PMID 26801246 DOI: 10.1186/S12943-016-0493-7  0.349
2016 Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, Li MS, Lau SS, Li X, Lee SD, Yang Y, ... ... Yu J, et al. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates Nuclear Factor-κB in hepatocellular carcinoma. The Journal of Pathology. PMID 26800240 DOI: 10.1002/Path.4688  0.304
2016 Wong CC, Li X, Qian Y, Xu J, Kang W, To KF, Sung J, Cai Z, Yu J. 676 SLC25A22 Is Essential for Supporting Aspartate Biosynthesis and Is a Specific Vulnerability in KRAS-Mutant Colorectal Cancer Gastroenterology. 150: S139. DOI: 10.1016/S0016-5085(16)30567-4  0.341
2016 Higashimori A, Dong YJ, Zhang Y, Nakatsu G, Ng SS, Arakawa T, Chan FK, Sung J, Yu J. 527 Forkhead Box F2 Suppresses Gastric Carcinogenesis Through Inhibiting Wnt Signaling By Promoting β-Catenin Degradation and Is Associated With Survival of Gastric Cancer Patients Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)30473-5  0.355
2016 Liang Q, Chan FK, Chiu J, Chen Y, Fang J, Brim H, Ashktorab H, Sung J, Yu J. 303 Fecal Bacteria Act as Novel Biomarkers for Non-Invasive Diagnosis of Colorectal Cancer Gastroenterology. 150: S69. DOI: 10.1016/S0016-5085(16)30349-3  0.337
2016 Tang J, Chen H, Fang J, Chan FK, Sung J, Yu J. 107 DEAD Box Polypeptide 27 Plays an Oncogenic Role in Colorectal Cancer Through Activating Nuclear Factor Kappa B Pathway Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)30218-9  0.329
2015 Huang T, Kang W, Cheng AS, Yu J, To KF. The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers. Bmc Cancer. 15: 950. PMID 26674478 DOI: 10.1186/S12885-015-1984-4  0.399
2015 Yau TO, Wu CW, Tang CM, Chen Y, Fang J, Dong Y, Liang Q, Ng SS, Chan FK, Sung JJ, Yu J. microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget. PMID 26621842 DOI: 10.18632/Oncotarget.6403  0.307
2015 Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, Ng SC, Tsoi H, Dong Y, Zhang N, He Y, Kang Q, Cao L, Wang K, Zhang J, ... ... Yu J, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nature Communications. 6: 8727. PMID 26515465 DOI: 10.1038/Ncomms9727  0.327
2015 Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao H, Stenvang J, Li Y, Wang X, Xu X, Chen N, Wu WK, Al-Aama J, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. PMID 26408641 DOI: 10.1136/Gutjnl-2015-309800  0.349
2015 Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, An HF, Weng YR, Yu J, Li M, Qin WX, Ma X, Shen N, Hong J, Fang JY. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget. PMID 26397137 DOI: 10.18632/Oncotarget.5166  0.359
2015 Xing R, Li L, Chen L, Gao Z, Wang H, Li W, Cui J, Tian G, Liang Q, Yu J, Sung JJ, Luo G, Gao H, Xu X, Yang H, et al. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells. Oncogene. PMID 26364607 DOI: 10.1038/Onc.2015.324  0.334
2015 Chen DH, Yu JW, Jiang BJ. Contactin 1: A potential therapeutic target and biomarker in gastric cancer. World Journal of Gastroenterology : Wjg. 21: 9707-16. PMID 26361417 DOI: 10.3748/wjg.v21.i33.9707  0.303
2015 Chen ZF, Ai LY, Wang JL, Ren LL, Yu YN, Xu J, Chen HY, Yu J, Li M, Qin WX, Ma X, Shen N, Chen YX, Hong J, Fang JY. Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiology. PMID 26346930 DOI: 10.2217/Fmb.15.66  0.356
2015 Li X, Liang Q, Liu W, Zhang N, Xu L, Zhang X, Zhang J, Sung JJ, Yu J. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway. Oncogene. PMID 26279301 DOI: 10.1038/Onc.2015.300  0.408
2015 Liu L, Cao L, Gong B, Yu J. Novel biomarkers for the identification and targeted therapy of gastric cancer. Expert Review of Gastroenterology & Hepatology. 9: 1217-26. PMID 26220043 DOI: 10.1586/17474124.2015.1072466  0.388
2015 Yang W, Mok MT, Li MS, Kang W, Wang H, Chan AW, Chou JL, Chen J, Ng EK, To KF, Yu J, Chan MW, Chan FK, Sung JJ, Cheng AS. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development. Oncogene. PMID 26212015 DOI: 10.1038/Onc.2015.276  0.42
2015 Wang K, Liang Q, Li X, Tsoi H, Zhang J, Wang H, Go MY, Chiu PW, Ng EK, Sung JJ, Yu J. MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome. Gut. PMID 26206665 DOI: 10.1136/Gutjnl-2015-309276  0.384
2015 Yu X, Li Z, Yu J, Chan MT, Wu WK. MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer. Cell Proliferation. PMID 26202377 DOI: 10.1111/Cpr.12202  0.33
2015 Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang K, Go MY, Ng SC, Chan FK, Sung JJ, Yu J. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis. Gut. PMID 26071132 DOI: 10.1136/Gutjnl-2014-308614  0.316
2015 Xu L, Li X, Cai M, Chen J, Li X, Wu WK, Kang W, Tong J, To KF, Guan XY, Sung JJ, Chan FK, Yu J. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer. Gut. PMID 25947013 DOI: 10.1136/Gutjnl-2014-308257  0.336
2015 Yu J, Wu WK, Liang Q, Zhang N, He J, Li X, Zhang X, Xu L, Chan MT, Ng SS, Sung JJ. Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer. Oncogene. PMID 25823027 DOI: 10.1038/Onc.2015.72  0.356
2015 Deng J, Liang H, Ying G, Dong Q, Zhang R, Yu J, Fan D, Hao X. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer. Oncotarget. 6: 4482-95. PMID 25714013 DOI: 10.18632/Oncotarget.2916  0.358
2015 Yu J, Blackford AL, Dal Molin M, Wolfgang CL, Goggins M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut. 64: 1783-9. PMID 25636698 DOI: 10.1136/Gutjnl-2014-308653  0.328
2015 Ren A, Dong Y, Tsoi H, Yu J. Detection of miRNA as non-invasive biomarkers of colorectal cancer. International Journal of Molecular Sciences. 16: 2810-23. PMID 25633103 DOI: 10.3390/Ijms16022810  0.329
2015 Ng JM, Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. International Journal of Molecular Sciences. 16: 2472-96. PMID 25622259 DOI: 10.3390/Ijms16022472  0.346
2015 Leung A, Tsoi H, Yu J. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert Review of Gastroenterology & Hepatology. 9: 651-7. PMID 25582922 DOI: 10.1586/17474124.2015.1001745  0.347
2015 Shen J, Xiao Z, Wu WK, Wang MH, To KF, Chen Y, Yang W, Li MS, Shin VY, Tong JH, Kang W, Zhang L, Li M, Wang L, Lu L, ... Yu J, et al. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Research. 75: 754-65. PMID 25503559 DOI: 10.1158/0008-5472.Can-14-1301  0.369
2015 Yu J, Wu WK, Li X, He J, Li XX, Ng SS, Yu C, Gao Z, Yang J, Li M, Wang Q, Liang Q, Pan Y, Tong JH, To KF, et al. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut. 64: 636-45. PMID 24951259 DOI: 10.1136/Gutjnl-2013-306620  0.31
2015 Deng J, Liang H, Ying G, Zhang R, Wang B, Yu J, Fan D, Hao X. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer. Oncotarget. 5: 3173-83. PMID 24833402 DOI: 10.18632/Oncotarget.1888  0.379
2015 Wen Z, Liu H, Li M, Li B, Gao W, Shao Q, Fan B, Zhao F, Wang Q, Xie Q, Yang Y, Yu J, Qu X. Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration. Oncogene. 34: 1241-52. PMID 24662827 DOI: 10.1038/Onc.2014.85  0.346
2015 Tian Y, To KF, Lai PBS, Cheung YS, Yu J, Wong VWS, Chan HLY, Cheng ASL. Abstract 2073: Histone deacetylase 8 impairs insulin sensitivity and activates β-catenin signaling in NAFLD-associated hepatocellular carcinoma Cancer Research. 75: 2073-2073. DOI: 10.1158/1538-7445.Am2015-2073  0.311
2015 Wong CC, Zhao L, Qian Y, Sung JJY, Yu J. Su1989 Inhibition of Protein Phosphatase 2A (PP2A) With LB-100 Enhances the Therapeutic Efficacy of Chemotherapy in Gastric Cancer Cells Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)31918-1  0.378
2015 Wong CC, Zhao L, Qian Y, Sung JJY, Yu J. 910 Cyclooxygenase-2/Prostaglandin E2 Pathway Promotes Aberrant DNA Methylation in Gastric Cancer: Role in Oncogenesis and Therapeutic Implications Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)30573-4  0.356
2015 Li L, Yue G, Lee J, Wong E, Chan K, Fung K, Yu J, Lau C, Chiu P. Investigation of the Combination Effects of Andrographis Paniculata With Chemotherapeutics for Esophageal Cancer Treatment Clinical Gastroenterology and Hepatology. 13: e80. DOI: 10.1016/J.Cgh.2015.04.056  0.34
2015 Zhang J, Tsoi H, Li X, Wang H, Gao J, Go MYY, Ng SC, Chan FKL, Sung JJY, Yu J. Carbonic Anhydrase IV Inhibits Colon Cancer Development by Inhibiting WNT Signaling Pathway Through Targeting WTAP-WT1-TBL1 Axis Clinical Gastroenterology and Hepatology. 13. DOI: 10.1016/J.Cgh.2015.04.053  0.306
2015 Wang K, Liang Q, Li X, Tsoi H, Zhang J, Wang H, Go M, Chiu P, Ng E, Sung J, Yu J. MAM Domain Containing Glycosylphosphatidylinositol Anchor 2 is a Novel Tumor Suppressor Cooperating With DNA Methyltransferase 1 Associated Protein 1 in Gastric Cancer and is Associated With Disease Outcome Clinical Gastroenterology and Hepatology. 13. DOI: 10.1016/J.Cgh.2015.04.052  0.343
2015 Yang W, Li MS, Kang W, Zeng L, Wang H, Chan AW, Ng EK, To KF, Chan FK, Yu J, Chan MW, Sung JJ, Cheng AS. Reactivation of Growth/Differentiation Factor 1 Contributes to the Chemopreventive Effect of 5-aza-2’deoxycytidine in Gastric Cancer Clinical Gastroenterology and Hepatology. 13: 214. DOI: 10.1016/J.Cgh.2014.09.008  0.352
2014 Dong Y, Yu J, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Management and Research. 6: 405-22. PMID 25342918 DOI: 10.2147/Cmar.S35164  0.305
2014 Zhang N, Chu ES, Zhang J, Li X, Liang Q, Chen J, Chen M, Teoh N, Farrell G, Sung JJ, Yu J. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway. Oncotarget. 5: 8330-40. PMID 25327562 DOI: 10.18632/Oncotarget.2212  0.324
2014 Kang W, Tong JH, Lung RW, Dong Y, Yang W, Pan Y, Lau KM, Yu J, Cheng AS, To KF. let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. Journal of Translational Medicine. 12: 281. PMID 25288334 DOI: 10.1186/S12967-014-0281-3  0.344
2014 Jiang L, Yang YD, Fu L, Xu W, Liu D, Liang Q, Zhang X, Xu L, Guan XY, Wu B, Sung JJ, Yu J. CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma. Oncotarget. 5: 7663-76. PMID 25277196 DOI: 10.18632/Oncotarget.2288  0.328
2014 Deng J, Liang H, Zhang R, Dong Q, Hou Y, Yu J, Fan D, Hao X. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer. Oncotarget. 5: 7420-30. PMID 25277182 DOI: 10.18632/Oncotarget.1973  0.322
2014 Deng J, Liang H, Ying G, Dong Q, Zhang L, Yu J, Fan D, Hao X. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. Journal of the American College of Surgeons. 219: 904-13. PMID 25260683 DOI: 10.1016/J.Jamcollsurg.2014.06.014  0.369
2014 Wang J, Dong L, Xu L, Chu ES, Chen Y, Shen J, Li X, Wong CC, Sung JJ, Yu J. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. Cancer Letters. 355: 192-200. PMID 25218345 DOI: 10.1016/J.Canlet.2014.08.025  0.331
2014 Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, Tang CM, Kang W, Lung RW, Li JW, Chan TF, Xing R, Lu Y, Lo KW, Wong N, ... Yu J, et al. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Gastroenterology. 147: 1350-62.e4. PMID 25173755 DOI: 10.1053/J.Gastro.2014.08.036  0.38
2014 Deng J, Liang H, Dong Q, Hou Y, Xie X, Yu J, Fan D, Hao X. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter. Open Biology. 4. PMID 25008234 DOI: 10.1098/Rsob.140067  0.329
2014 Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, Go MY, Ng EK, Arakawa T, Chan FK, Sung JJ, Yu J. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. The Journal of Pathology. 234: 302-15. PMID 24931004 DOI: 10.1002/Path.4391  0.427
2014 Yau TO, Tang CM, Yu J. Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments. World Journal of Gastroenterology : Wjg. 20: 6448-56. PMID 24914366 DOI: 10.3748/Wjg.V20.I21.6448  0.337
2014 Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu CW, Wang K, Zheng S, Ng SS, Chan FK, Sung JJ, Yu J. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Molecular Cancer. 13: 124. PMID 24885920 DOI: 10.1186/1476-4598-13-124  0.353
2014 Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins M. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget. 5: 2575-87. PMID 24810906 DOI: 10.18632/Oncotarget.1842  0.381
2014 Kang W, Tong JH, Chan AW, Zhao J, Wang S, Dong Y, Sin FM, Yeung S, Cheng AS, Yu J, To K. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma. Oncology Reports. 31: 2579-86. PMID 24756820 DOI: 10.3892/Or.2014.3148  0.405
2014 Yu C, Yu J, Yao X, Wu WK, Lu Y, Tang S, Li X, Bao L, Li X, Hou Y, Wu R, Jian M, Chen R, Zhang F, Xu L, et al. Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing. Cell Research. 24: 701-12. PMID 24699064 DOI: 10.1038/Cr.2014.43  0.337
2014 Kang W, Tong JH, Chan AW, Zhao J, Dong Y, Wang S, Yang W, Sin FM, Ng SS, Yu J, Cheng AS, To KF. Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. Journal of Translational Medicine. 12: 80. PMID 24674326 DOI: 10.1186/1479-5876-12-80  0.407
2014 Kang W, Tong JH, Chan AW, Cheng AS, Yu J, To K. MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function. Oncology Reports. 31: 2071-8. PMID 24647462 DOI: 10.3892/Or.2014.3094  0.38
2014 Zhang L, Sung JJ, Yu J, Ng SC, Wong SH, Cho CH, Ng SS, Chan FK, Wu WK. Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer. The Journal of Pathology. 233: 103-12. PMID 24633785 DOI: 10.1002/Path.4351  0.345
2014 Wu X, Zeng Z, Xu L, Yu J, Cao Q, Chen M, Sung JJ, Hu P. Increased expression of IL17A in human gastric cancer and its potential roles in gastric carcinogenesis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 5347-56. PMID 24570184 DOI: 10.1007/S13277-014-1697-3  0.411
2014 Wu WK, Sung JJ, Cheng AS, Chan FK, Ng SS, To KF, Wang XJ, Zhang L, Wong SH, Yu J, Cho CH. The Janus face of cathelicidin in tumorigenesis. Current Medicinal Chemistry. 21: 2392-400. PMID 24524763 DOI: 10.2174/0929867321666140205135351  0.3
2014 Wang Y, Ren F, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJY, Xu J, Zeps N, Chang Z. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer Carcinogenesis. 35: 983-991. PMID 24302614 DOI: 10.1093/Carcin/Bgt393  0.348
2014 Wang C, Wu WK, Liu X, To KF, Chen GG, Yu J, Ng EK. Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study. Peptides. 51: 131-8. PMID 24274970 DOI: 10.1016/J.Peptides.2013.10.009  0.374
2014 Choi GC, Li J, Wang Y, Li L, Zhong L, Ma B, Su X, Ying J, Xiang T, Rha SY, Yu J, Sung JJ, Tsao SW, Chan AT, Tao Q. The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation. Molecular Cancer Research : McR. 12: 228-38. PMID 24184540 DOI: 10.1158/1541-7786.Mcr-13-0195  0.342
2014 Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, Yu J, Carrasquilla G, Sung JJ, Alvarado-Cabrero I, Lissowska J, Meneses-Gonzalez F, Yatabe Y, Ding T, et al. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. International Journal of Cancer. Journal International Du Cancer. 134: 948-53. PMID 23904115 DOI: 10.1002/Ijc.28402  0.339
2014 Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 63: 236-43. PMID 23580779 DOI: 10.1136/Gutjnl-2013-304531  0.326
2014 Lei R, Tang J, Zhuang X, Deng R, Li G, Yu J, Liang Y, Xiao J, Wang HY, Yang Q, Hu G. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene. 33: 1287-96. PMID 23474751 DOI: 10.1038/Onc.2013.65  0.309
2014 Yang WQ, Li MSM, Kang W, Zeng LH, Wang TH, Chan AW, Ng EKW, To KF, Chan FKL, Yu J, Chan MWY, Sung JJY, Cheng ASL. Abstract 1245: Reactivation of growth/differentiation factor 1 contributes to the chemopreventive effect of 5-aza-2′deoxycytidine in gastric cancer Cancer Research. 74: 1245-1245. DOI: 10.1158/1538-7445.Am2014-1245  0.404
2014 Wang K, Liang Q, Li X, Chu ES, Shen J, Go MY, Sung JJY, Yu J. Tu1650 Promoter Hypermethylation of a Novel Tumor Suppressor MDGA2 Predicts Poor Prognosis in Gastric Cancer Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)62926-7  0.386
2014 Wang S, Dong YJ, Xu L, Li X, Ng SS, Sung JJY, Yu J. Tu1647 DACT2 Is a Functional Tumor Suppressor Through Inhibiting Wnt/β-Catenin Pathway and Associated With Poor Survival in Colon Cancer Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)62923-1  0.333
2014 Zhang J, Li X, Wang J, Gao J, Go MY, Sung JJY, Yu J. 945 Promoter Hypermethylation of a Novel Tumor Suppressor Gene CA4 Associated With Colon Cancer Recurrence Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)60587-4  0.324
2014 Amato E, Molin Md, Mafficini A, Yu J, Malleo G, Rusev B, Fassan M, Antonello D, Sadakari Y, Castelli P, Zamboni G, Maitra A, Salvia R, Hruban R, Bassi C, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. Pancreatology. 14. DOI: 10.1016/J.Pan.2014.05.786  0.316
2013 Yang Q, Gao J, Xu L, Zeng Z, Sung JJ, Yu J. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 18: 721-5. PMID 24191714 DOI: 10.3109/1354750X.2013.853839  0.371
2013 Wong SH, Sung JJ, Chan FK, To KF, Ng SS, Wang XJ, Yu J, Wu WK. Genome-wide association and sequencing studies on colorectal cancer. Seminars in Cancer Biology. 23: 502-11. PMID 24096009 DOI: 10.1016/J.Semcancer.2013.09.005  0.347
2013 Pan Y, Huang J, Xing R, Yin X, Cui J, Li W, Yu J, Lu Y. Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection. Journal of Translational Medicine. 11: 173. PMID 23870553 DOI: 10.1186/1479-5876-11-173  0.358
2013 Otani K, Li X, Arakawa T, Chan FK, Yu J. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer. Expert Review of Molecular Diagnostics. 13: 445-55. PMID 23782252 DOI: 10.1586/Erm.13.32  0.389
2013 Zhao J, Liang Q, Cheung KF, Kang W, Dong Y, Lung RW, Tong JH, To KF, Sung JJ, Yu J. Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. British Journal of Cancer. 108: 2557-64. PMID 23722468 DOI: 10.1038/Bjc.2013.263  0.37
2013 Ren SX, Shen J, Cheng AS, Lu L, Chan RL, Li ZJ, Wang XJ, Wong CC, Zhang L, Ng SS, Chan FL, Chan FK, Yu J, Sung JJ, Wu WK, et al. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. Plos One. 8: e63641. PMID 23700428 DOI: 10.1371/Journal.Pone.0063641  0.304
2013 Cheung KF, Zhao J, Hao Y, Li X, Lowe AW, Cheng AS, Sung JJ, Yu J. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth. Cancer. 119: 1217-26. PMID 23212831 DOI: 10.1002/Cncr.27865  0.35
2013 Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene. 32: 5078-88. PMID 23208495 DOI: 10.1038/Onc.2012.526  0.352
2013 Tang CM, Yu J. Hypoxia-inducible factor-1 as a therapeutic target in cancer. Journal of Gastroenterology and Hepatology. 28: 401-5. PMID 23173651 DOI: 10.1111/Jgh.12038  0.358
2013 Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, Go MY, Lee CC, Ling TK, Ng EK, Yu J, Huang TH, To KF, Chan MW, Sung JJ, et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology. 144: 122-133.e9. PMID 23058321 DOI: 10.1053/J.Gastro.2012.10.002  0.396
2013 Du W, Wang S, Zhou Q, Li X, Chu J, Chang Z, Tao Q, Ng EK, Fang J, Sung JJ, Yu J. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene. 32: 3319-28. PMID 22907434 DOI: 10.1038/Onc.2012.359  0.419
2013 Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang P, Chan LK, Zhang T, Yu J, Kwong J, Cheung TH, Chung T, Mak K, Sun H, Wang H. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma. Oncogene. 32: 3432-42. PMID 22907428 DOI: 10.1038/Onc.2012.360  0.3
2013 Zhao J, Liang Q, Cheung KF, Kang W, Lung RW, Tong JH, To KF, Sung JJ, Yu J. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer. 119: 304-12. PMID 22833454 DOI: 10.1002/Cncr.27724  0.335
2013 Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang H, Kang W, Li X, Tao Q, Sung JJ, Yu J. Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut. 62: 833-41. PMID 22580414 DOI: 10.1136/Gutjnl-2011-301776  0.41
2013 Yu J, Liang QY, Wang J, Cheng Y, Wang S, Poon TC, Go MY, Tao Q, Chang Z, Sung JJ. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer. Oncogene. 32: 307-17. PMID 22370639 DOI: 10.1038/Onc.2012.54  0.424
2013 Camargo MC, Koriyama C, Matsuo K, Kim W, Herrera-Goepfert R, Liao LM, Gonzalez C, Yu J, Sung J, Lissowska J, Meneses-Gonzalez F, Yatabe Y, Gulley M, Akiba S, Rabkin CS. Abstract 4808: Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Cancer Research. 73: 4808-4808. DOI: 10.1158/1538-7445.Am2013-4808  0.352
2013 Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KAT, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, ... Yu J, et al. Erratum: Corrigendum: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma Nature. 494: 390-390. DOI: 10.1038/Nature11864  0.343
2013 Yu J, Wu WK, He J, Li X, Xu L, Zhang X, Sung JJ. Su2001 A Novel Oncogenic Recurrent Point Mutation in Akr1c2 in Chinese Colon Cancer Patients Gastroenterology. 144: S-528. DOI: 10.1016/S0016-5085(13)61963-0  0.317
2013 Liang Q, Yao X, Tang S, Yau TO, Zhao J, Sung JJY, Yu J. Su1990 Integrative Identification of EBV-Associated Variations At Genomic, Epigenomic and Transcriptomic Levels in Gastric Cancer Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)61952-6  0.349
2013 Zhang L, Dong YJ, Zhu N, Wu C, Zhao J, Sung JJY, Ng S, Yu J. Sa1706 MicroRNA-139-5p Exerts Tumor Suppressor Function by Targeting Notch1 and Jun in Colorectal Cancer Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)61019-7  0.353
2013 Zhao J, Kang W, Dong YJ, Go MY, Tong JH, To KF, Cheng AS, Sung JJY, Yu J. Sa1692 Characterization of the Helicobacter pylori-Induced STAT3 Activation and the Associated Signaling Network in Gastric Cancer Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)61005-7  0.348
2013 Otani K, Dong YJ, Zhang N, Xu L, Zhao J, Liang Q, Mok MT, Li X, Go MY, Chan FK, Sung JJ, Yu J. 875 Odd-Skipped Related 1 Is a Novel Tumor Suppressor Gene in Gastric Cancer Gastroenterology. 144: S-153. DOI: 10.1016/S0016-5085(13)60550-8  0.371
2013 Xu L, Li X, Zhang X, Zhang N, Sung JJ, Chan FK, Yu J. 679 Identification and Characterization of a Novel Amplification Gene Slc12a5 in Colorectal Cancer Gastroenterology. 144: S-124. DOI: 10.1016/S0016-5085(13)60446-1  0.352
2012 He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Molecular Medicine (Cambridge, Mass.). 18: 1491-8. PMID 23255074 DOI: 10.2119/Molmed.2012.00304  0.319
2012 Ren SX, Cheng AS, To KF, Tong JH, Li MS, Shen J, Wong CC, Zhang L, Chan RL, Wang XJ, Ng SS, Chiu LC, Marquez VE, Gallo RL, Chan FK, Yu J, et al. Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. Cancer Research. 72: 6512-23. PMID 23100468 DOI: 10.1158/0008-5472.Can-12-2359  0.369
2012 Wang S, Kang W, Go MY, Tong JH, Li L, Zhang N, Tao Q, Li X, To KF, Sung JJ, Yu J. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway. Molecular Medicine (Cambridge, Mass.). 18: 1402-11. PMID 23073659 DOI: 10.2119/Molmed.2012.00243  0.415
2012 Yu J, Walter K, Omura N, Hong SM, Young A, Li A, Vincent A, Goggins M. Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine. Plos One. 7: e43456. PMID 22984426 DOI: 10.1371/Journal.Pone.0043456  0.352
2012 Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, ... Yu J, et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature. 486: 266-70. PMID 22699621 DOI: 10.1038/Nature11114  0.335
2012 Wu YC, Wang XJ, Yu L, Chan FK, Cheng AS, Yu J, Sung JJ, Wu WK, Cho CH. Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells. Plos One. 7: e37572. PMID 22679478 DOI: 10.1371/Journal.Pone.0037572  0.303
2012 Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML, Axilbund J, Schulick R, Ali SZ, Eshleman JR, Velculescu VE, et al. ATM mutations in patients with hereditary pancreatic cancer Cancer Discovery. 2: 41-46. PMID 22585167 DOI: 10.1158/2159-8290.Cd-11-0194  0.314
2012 Kang W, Tong JH, Chan AW, Lung RW, Chau SL, Wong QW, Wong N, Yu J, Cheng AS, To KF. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. Plos One. 7: e33919. PMID 22470493 DOI: 10.1371/Journal.Pone.0033919  0.409
2012 Wang L, Chen S, Xue M, Zhong J, Wang X, Gan L, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Jin H, Si J. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Molecular Medicine (Cambridge, Mass.). 18: 389-400. PMID 22160393 DOI: 10.2119/Molmed.2011.00172  0.409
2012 Li X, Cheung KF, Ma X, Tian L, Zhao J, Go MYY, Shen B, Cheng ASL, Ying J, Tao Q, Sung JJY, Kung HF, Yu J. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients Oncogene. 31: 3419-3430. PMID 22105368 DOI: 10.1038/Onc.2011.511  0.417
2012 Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q, Jin H, Zeng Z, Sung JJ, Yu J. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut. 61: 977-85. PMID 21917650 DOI: 10.1136/Gutjnl-2011-300411  0.394
2012 Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee CW, Chan FK, Yu J, Sung JJ. The autophagic paradox in cancer therapy. Oncogene. 31: 939-53. PMID 21765470 DOI: 10.1038/Onc.2011.295  0.363
2012 Cheung KF, Lam CN, Wu K, Ng EK, Chong WW, Cheng AS, To KF, Fan D, Sung JJ, Yu J. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer. 118: 947-59. PMID 21717426 DOI: 10.1002/Cncr.26189  0.411
2012 Zhao J, Jin H, Cheung KF, Tong JH, Zhang S, Go MY, Tian L, Kang W, Leung PP, Zeng Z, Li X, To KF, Sung JJ, Yu J. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Cancer. 118: 924-36. PMID 21717425 DOI: 10.1002/Cncr.26184  0.397
2012 Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy M, Gallinger S, Schwartz AG, Syngal S, Cote ML, Axilbund J, Schulick R, Ali SZ, Eshleman JR, Velculescu V, et al. Abstract 2628: Genome-wide sequencing identifiesATMas a pancreatic cancer susceptibility gene Cancer Research. 72: 2628-2628. DOI: 10.1158/1538-7445.Am2012-2628  0.317
2012 Camargo MC, Kim WH, Chiaravalli AM, Kim K, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Ngoan LT, Chow W, Lissowska J, et al. Mo1587 Epstein-Barr Virus Positivity as a Prognostic Indicator in Gastric Cancer: an International Pooled Analysis Gastroenterology. 142: S-635. DOI: 10.1016/S0016-5085(12)62442-1  0.325
2012 Zhao J, Liang Q, Kang W, Lung RW, Tong JH, To KF, Sung JJ, Yu J. Su1863 Genome-Wide Identification of Epstein-Barr Virus (EBV) Driven Gastric Cancer-Related DNA Methylation by Medip-Chip Profiling of EBV Infected AGS Cells Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62002-2  0.322
2012 Du W, Wang S, Li X, Tao Q, Fang J, Sung JJ, Yu J. Su1861 A Disintegrin-Like and Metalloprotease With Thrombospondin Type 1 Motif 9 is a Functional Tumor Suppressor in Gastric Cancer Through Inhibiting AKT/mTOR Pathway Gastroenterology. 142: S-521. DOI: 10.1016/S0016-5085(12)62000-9  0.305
2012 He XQ, Wu C, Dong YJ, Ng S, Chan FKL, Sung JJ, Yu J. 1052 MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer Cells by Downregulating Oncogene BMI1 Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60695-7  0.342
2012 Dong YJ, Wu C, He XQ, Zhang N, Sung JJ, Ng S, Yu J. 1051 MiR-133a Inhibits Colorectal Cancer Cell Growth by Direct Targeting E3 Ubiquitin Ligase RFFL and Activating p53-p21CIP1/WAF1 Pathway Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60694-5  0.312
2012 Wang S, Du W, Li X, Tao Q, Sung JJ, Yu J. 56 Zinc Finger Protein 545 is a Functional Tumor Suppressor Through Inhibiting Ribosomal RNA Transcription in Gastric Cancer Gastroenterology. 142: S-15. DOI: 10.1016/S0016-5085(12)60056-0  0.37
2012 Wu C, Dong YJ, He XQ, Ng S, Chan FKL, Sung JJ, Yu J. 40 MicroRNA-18a Attenuates DNA Damage Repair by Directly Controlling the Expression of ATM in Colon Cancer Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60040-7  0.309
2011 Bi F, Li Q, Zhou C, Yu J, Cai X, Qiu M, Liu J, Yi C, Luo D, Xu F. Preliminary results of a randomized phase II study: Treatment of Chinese patients with advanced gastric cancer with FOLFIRI followed by FOLFOX7 or the reverse sequence. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4064. PMID 28020482 DOI: 10.1200/Jco.2011.29.15_Suppl.4064  0.354
2011 Xu L, Zeng Z, Chen B, Wu X, Yu J, Xue L, Tian L, Wang Y, Chen M, Sung JJ, Hu P. Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study. Oncology Letters. 2: 371-377. PMID 22866090 DOI: 10.3892/Ol.2011.249  0.374
2011 Shu XS, Geng H, Li L, Ying J, Ma C, Wang Y, Poon FF, Wang X, Ying Y, Yeo W, Srivastava G, Tsao SW, Yu J, Sung JJ, Huang S, et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors. Plos One. 6: e27346. PMID 22087297 DOI: 10.1371/Journal.Pone.0027346  0.349
2011 Yu J, Jia Y, Cheung KF, Zeng Z, Tian L, Wang S, Hu P, Sung JJ. Polymorphisms in interleukin-6-6331 influences the susceptibility of a Chinese population to gastric cancer. Cancer Investigation. 29: 564-72. PMID 21843047 DOI: 10.3109/07357907.2011.605411  0.364
2011 Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J, Lai PB, To KF, Sung JJ. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. The Journal of Clinical Investigation. 121: 3159-75. PMID 21747169 DOI: 10.1172/Jci45967  0.332
2011 Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, et al. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Research. 71: 4028-39. PMID 21512140 DOI: 10.1158/0008-5472.Can-10-3342  0.319
2011 Wu WK, Lee CW, Cho CH, Chan FK, Yu J, Sung JJ. RNA interference targeting raptor inhibits proliferation of gastric cancer cells. Experimental Cell Research. 317: 1353-8. PMID 21396933 DOI: 10.1016/J.Yexcr.2011.03.005  0.388
2011 Wang S, Zhang M, Zeng Z, Tian L, Wu K, Chu J, Fan D, Hu P, Sung JJ, Yu J. IκBα polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study. Life Sciences. 88: 792-7. PMID 21376060 DOI: 10.1016/J.Lfs.2011.02.016  0.337
2011 Gan L, Chen S, Zhong J, Wang X, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Si J, Wang L, Jin H. ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. Plos One. 6: e16916. PMID 21347233 DOI: 10.1371/Journal.Pone.0016916  0.395
2011 Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, So KK, Wu K, Fan D, Yu J, Sung JJ, To KF. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2130-9. PMID 21346147 DOI: 10.1158/1078-0432.Ccr-10-2467  0.424
2011 Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G, Li L, Dai N, Si J, Tao Q, Sung JJ, Yu J. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology (Baltimore, Md.). 53: 843-53. PMID 21319196 DOI: 10.1002/Hep.24124  0.347
2011 Zeng Z, Wu X, Chen F, Yu J, Xue L, Hao Y, Wang Y, Chen M, Sung JJ, Hu P. Polymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese. Molecular Carcinogenesis. 50: 353-8. PMID 21268123 DOI: 10.1002/Mc.20718  0.367
2011 Chen B, Zeng Z, Xu L, Wu X, Yu J, Xue L, Hao Y, Wang Y, Sung JJ, Chen M, Hu P. IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a case-control study. Cancer Epidemiology. 35: 165-9. PMID 20863779 DOI: 10.1016/J.Canep.2010.08.006  0.355
2011 Cheng AS, Feng H, Tsang DP, Li MS, Go MY, Cheung SY, Ng SS, Lin MC, To KF, Yu J, Lai PB, Sung JJ. Abstract 2170: Dissecting the oncogenic function of a novel androgen receptor-dependent direct target, cell cycle-related kinase (CCRK), in hepatocellular carcinoma Cancer Research. 71: 2170-2170. DOI: 10.1158/1538-7445.Am2011-2170  0.34
2011 Cheng AS, Li MS, Sung JG, Shin VY, Chan MW, To KF, Yu J, Sung JJ. Global Analysis of Helicobacter pylori-Associated CpG Promoter Methylation Reveals Epigenetic Silencing of Collagen Type XIV Alpha 1 in Gastric Cancer Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63422-7  0.334
2011 Cheng AS, Li MS, Kang W, Chou J, Cheng YY, Huang TH, Yu J, To KF, Sung JJ, Chan MW, Chan FKL. Integrated Genome-Wide Analysis of Promoter Methylation and FOXD3 Binding in Gastric Cancer Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63389-1  0.347
2011 Yu J, Wang J, Liang Q, Cheung K, Wang S, Go MY, Tao Q, Sung JJ. Zinc Finger Protein 331, a Novel Putative Tumor Suppressor, Suppresses Growth and Invasiveness of Gastric Cancer Cells Gastroenterology. 140: S-818-S-819. DOI: 10.1016/S0016-5085(11)63388-X  0.38
2011 Zhao J, Cheung K, Kang W, Tong JH, To KF, Sung JJ, Yu J. Somatostatin Receptor 1, a Novel EBV-Driven CpG Hypermethylated Gene, Contributes to the Pathogenesis of EBV- Associated Gastric Cancer Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)61419-4  0.365
2011 Wang S, Go MY, Chu ES, Cheung K, Li X, Kang W, Tong JH, Tao Q, To KF, Sung JJ, Yu J. DACT1 is Silenced by CpG Methylation in Gastric Cancer and Contributes to the Pathogenesis of Gastric Cancer Gastroenterology. 140: S-157. DOI: 10.1016/S0016-5085(11)60637-9  0.373
2011 Xu L, Li X, Chu ES, Zhao G, Go MY, Zeng Z, Tao Q, Sung JJ, Yu J. Epigenetic Inactivation of BCL6B, a Functional Tumor Suppressor for Gastric Cancer, is Associated With Poor Survival of Gastric Cancer Gastroenterology. 140: S-157. DOI: 10.1016/S0016-5085(11)60636-7  0.4
2011 Liu W, Li X, Chu ES, Go MY, Sung JJ, Yu J. Paired Box Gene 5 is a Novel Tumor Suppressor Involved in the Pathogenesis of Hepatocellular Carcinoma Through Interaction With p53 Signaling Pathway Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)60589-1  0.401
2011 Wu C, Dong YJ, Ng S, Leung WW, Wong CY, Sung JJ, Chan FKL, Yu J. Identification of a Panel of MicroRNAs in Stool as Screening Markers for Colorectal Cancer Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)60297-7  0.323
2010 Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, Nakata K, Yu J, Kayashima T, Souzaki R, Tajiri T, Manabe T, Ohtsuka T, Tanaka M. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia (New York, N.Y.). 12: 807-17. PMID 20927319 DOI: 10.1593/Neo.10458  0.312
2010 Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 29: 5761-71. PMID 20802530 DOI: 10.1038/Onc.2010.352  0.332
2010 Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene. 29: 6464-74. PMID 20802524 DOI: 10.1038/Onc.2010.370  0.404
2010 Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biology & Therapy. 10: 748-757. PMID 20703102 DOI: 10.4161/Cbt.10.8.13083  0.334
2010 Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas Human Pathology. 41: 1466-1474. PMID 20619441 DOI: 10.1016/J.Humpath.2010.04.004  0.303
2010 Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D, Wu K, Yu J, Sung JJ, Cho CH. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. International Journal of Cancer. Journal International Du Cancer. 127: 1741-7. PMID 20521250 DOI: 10.1002/Ijc.25489  0.331
2010 Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, Sung JJ. Dysregulation of cellular signaling in gastric cancer. Cancer Letters. 295: 144-53. PMID 20488613 DOI: 10.1016/J.Canlet.2010.04.025  0.332
2010 Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, ... Yu J, et al. International network of cancer genome projects. Nature. 464: 993-8. PMID 20393554 DOI: 10.1038/Nature08987  0.331
2010 Wu WK, Sung JJ, Lee CW, Yu J, Cho CH. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Letters. 295: 7-16. PMID 20381235 DOI: 10.1016/J.Canlet.2010.03.015  0.367
2010 Wu WK, Cho CH, Lee CW, Wu K, Fan D, Yu J, Sung JJ. Proteasome inhibition: a new therapeutic strategy to cancer treatment. Cancer Letters. 293: 15-22. PMID 20133049 DOI: 10.1016/J.Canlet.2009.12.002  0.326
2010 Wang S, Tian L, Zeng Z, Zhang M, Wu K, Chen M, Fan D, Hu P, Sung JJ, Yu J. IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese. Bmc Gastroenterology. 10: 15. PMID 20132559 DOI: 10.1186/1471-230X-10-15  0.353
2010 Wu WK, Cho CH, Lee CW, Wu YC, Yu L, Li ZJ, Wong CC, Li HT, Zhang L, Ren SX, Che CT, Wu K, Fan D, Yu J, Sung JJ. Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells. Autophagy. 6: 228-38. PMID 20087064 DOI: 10.4161/Auto.6.2.11042  0.368
2010 Wu WK, Sung JJ, To KF, Yu L, Li HT, Li ZJ, Chu KM, Yu J, Cho CH. The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells. Journal of Cellular Physiology. 223: 178-86. PMID 20054823 DOI: 10.1002/Jcp.22026  0.403
2010 Wu X, Zeng Z, Chen B, Yu J, Xue L, Hao Y, Chen M, Sung JJ, Hu P. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. International Journal of Cancer. Journal International Du Cancer. 127: 86-92. PMID 19904747 DOI: 10.1002/Ijc.25027  0.345
2010 Yu J, Zeng Z, Wang S, Tian L, Wu J, Xue L, Lee CW, Zhang M, Goggins WB, Chen M, Hu P, Sung JJ. IL-1B-511 polymorphism is associated with increased risk of certain subtypes of gastric cancer in Chinese: a case-control study. The American Journal of Gastroenterology. 105: 557-64. PMID 19904240 DOI: 10.1038/Ajg.2009.644  0.314
2010 Liu X, Wang X, Zhang J, Lam EK, Shin VY, Cheng AS, Yu J, Chan FK, Sung JJ, Jin HC. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene. 29: 442-50. PMID 19881551 DOI: 10.1038/Onc.2009.332  0.407
2010 Bi F, Li Q, Zhou C, Yu J, Cai X, Qiu M, Liu J, Yi C, Luo D, Xu F. Treatment of Chinese patients with advanced gastric cancer with FOLFIRI followed by FOLFOX7 or the reverse sequence. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.Tps207  0.353
2010 Zhao J, Jin H, Cheung K, Zhang S, Li X, Chu ES, Wu C, Sung JJ, Yu J. M1912 Role of Zinc Finger E-Box Binding Factor 1 Modulating Latent-Lytic Switch of Epstein-Barr Virus in Gastric Cancer Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62023-9  0.367
2010 Wu C, Ng SS, Leung WW, Lee CW, Wong CY, Yu J, Sung JJ. S1164 MicroRNAs in Stool as Screening Marker for Colorectal Cancer Gastroenterology. 138: S-194. DOI: 10.1016/S0016-5085(10)60880-3  0.32
2010 Yu J, Ma X, Cheung K, Li X, Wu C, Wang S, Ng SS, Sung JJ. 682 Inactivation of T-Box 5 (Tbx5) Gene in Colon Cancer and Its Potential Application Gastroenterology. 138: S-93-S-94. DOI: 10.1016/S0016-5085(10)60427-1  0.305
2010 Li X, Cheung K, Zhao J, Ma X, Go MY, Chu ES, Cheng AS, Tao Q, Sung JJ, Kung H, Yu J. 22 Epigenetic Identification of Paired Box Gene 5 as a Functional Tumor Suppressor Associated With Poor Prognosis in Patients With Gastric Cancer Gastroenterology. 138: S-4. DOI: 10.1016/S0016-5085(10)60016-9  0.382
2009 Liu X, Lam EK, Wang X, Zhang J, Cheng YY, Lam YW, Ng EK, Yu J, Chan FK, Jin H, Sung JJ. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 30: 242-8. PMID 19816091 DOI: 10.1159/000243767  0.413
2009 Fujita H, Ohuchida K, Mizumoto K, Egami T, Miyoshi K, Moriyama T, Cui L, Yu J, Zhao M, Manabe T, Tanaka M. Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Science. 100: 2309-17. PMID 19735487 DOI: 10.1111/J.1349-7006.2009.01317.X  0.354
2009 Li J, Ng EK, Ng YP, Wong CY, Yu J, Jin H, Cheng VY, Go MY, Cheung PK, Ebert MP, Tong J, To KF, Chan FK, Sung JJ, Ip NY, et al. Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer. British Journal of Cancer. 101: 691-8. PMID 19672268 DOI: 10.1038/Sj.Bjc.6605202  0.415
2009 Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Röcken C, Ebert MP, Kwok TT, Sung JJ. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. British Journal of Cancer. 101: 699-706. PMID 19638978 DOI: 10.1038/Sj.Bjc.6605195  0.348
2009 Li H, Wu WK, Zheng Z, Che CT, Yu L, Li ZJ, Wu YC, Cheng KW, Yu J, Cho CH, Wang M. 2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules. Biochemical Pharmacology. 78: 1224-32. PMID 19591809 DOI: 10.1016/J.Bcp.2009.06.109  0.327
2009 Nakata K, Ohuchida K, Nagai E, Hayashi A, Miyasaka Y, Kayashima T, Yu J, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M. LMO2 Is a Novel Predictive Marker for a Better Prognosis in Pancreatic Cancer Neoplasia. 11: 712-719. PMID 19568416 DOI: 10.1593/Neo.09418  0.369
2009 Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World Journal of Gastroenterology. 15: 2731-8. PMID 19522023 DOI: 10.3748/Wjg.15.2731  0.333
2009 Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, Luo B, Zhang Q, Mok TS, Zheng W, Qiu X, ... Yu J, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Research. 69: 5194-201. PMID 19509237 DOI: 10.1158/0008-5472.Can-08-3694  0.348
2009 Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, Takahata S, Toma H, Nagai E, Tanaka M. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Molecular Cancer Therapeutics. 8: 1067-1074. PMID 19435867 DOI: 10.1158/1535-7163.Mct-08-0592  0.337
2009 Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 58: 1375-81. PMID 19201770 DOI: 10.1136/Gut.2008.167817  0.326
2009 Ying J, Poon FF, Yu J, Geng H, Wong AH, Qiu GH, Goh HK, Rha SY, Tian L, Chan AT, Sung JJ, Tao Q. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers. British Journal of Cancer. 100: 663-9. PMID 19156137 DOI: 10.1038/Sj.Bjc.6604888  0.38
2009 Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 136: 640-51.e1. PMID 19084528 DOI: 10.1053/J.Gastro.2008.10.050  0.387
2009 Yu J, Tao Q, Cheng YY, Lee KY, Ng SS, Cheung KF, Tian L, Rha SY, Neumann U, Röcken C, Ebert MP, Chan FK, Sung JJ. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer. 115: 49-60. PMID 19051296 DOI: 10.1002/Cncr.23989  0.379
2009 Ohhashi S, Ohuchida K, Mizumoto K, Egami T, Yu J, Cui L, Toma H, Takahata S, Nabae T, Tanaka M. Midkine mRNA is overexpressed in pancreatic cancer Digestive Diseases and Sciences. 54: 811-815. PMID 18712601 DOI: 10.1007/S10620-008-0434-4  0.322
2009 Wu CW, Yu J, Sung JJY. Peroxisome proliferator-activated receptor δ and gastric cancer (Review) Oncology Reports. 22: 451-457. DOI: 10.3892/Or_00000456  0.352
2009 Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT. T1994 Oncofetal H19-Derived miR-675 Regulates Tumor Suppressor Retinoblastoma in Human Colorectal Cancer Gastroenterology. 136: A-616. DOI: 10.1016/S0016-5085(09)62840-7  0.312
2009 Yu J, Jia Y, Cheung K, Zeng Z, Tian L, Wang S, Hu P, Sung JJ. S1955 Polymorphisms in Interleukin-6-6331 Influences the Susceptibility of a Chinese Population to Gastric Cancer Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)61371-8  0.327
2009 Liu X, Jin H, Lam EK, Wang X, Lam YW, Cheng YY, Yu J, Chan FKL, Sung JJ. 1089 Promoter Hypermethylation Mediates Downregulation of Thiamin Receptor SLC19A3 But Not SLC19A2 in Gastric Cancer Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)60756-3  0.352
2009 Sung JJ, Chong WS, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Ng EK. 1070 Differential Expression of MicroRNAs in Plasma of Colorectal Cancer Patients: A Potential Marker for Colorectal Cancer Screening Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)60743-5  0.313
2009 Ng EK, Tsang WP, Ng SS, Jin H, Yu J, Röcken C, Ebert MP, Sung JJ, Kwok TT. 1069 MicroRNA-143 Is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer Gastroenterology. 136: A-165. DOI: 10.1016/S0016-5085(09)60742-3  0.319
2008 Cheng YY, Jin H, Liu X, Siu JM, Wong YP, Ng EK, Yu J, Leung WK, Sung JJ, Chan FK. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. British Journal of Cancer. 99: 2083-7. PMID 18985039 DOI: 10.1038/Sj.Bjc.6604760  0.393
2008 Shin VY, Jin HC, Ng EK, Yu J, Leung WK, Cho CH, Sung JJ. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways. Toxicology and Applied Pharmacology. 233: 254-61. PMID 18805435 DOI: 10.1016/J.Taap.2008.08.012  0.301
2008 Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Röcken C, Ebert MPA, Chan ATC, Sung JJY. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors Hepatology. 48: 508-518. PMID 18666234 DOI: 10.1002/Hep.22343  0.351
2008 Leung WK, Wu KC, Wong CY, Cheng AS, Ching AK, Chan AW, Chong WW, Go MY, Yu J, To KF, Wang X, Chui YL, Fan DM, Sung JJ. Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice. Carcinogenesis. 29: 1648-54. PMID 18611916 DOI: 10.1093/Carcin/Bgn156  0.373
2008 Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, et al. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene. 27: 5267-76. PMID 18469857 DOI: 10.1038/Onc.2008.147  0.328
2008 Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 55-61. PMID 18172252 DOI: 10.1158/1078-0432.Ccr-07-1644  0.337
2008 Ng EK, Wang R, Yu J, Li MY, Leung BC, Chen GG. T2059 Inhibition of Heme Oxygenase-1 By Znpp Enhances the Sensitivity of Gastric Cancer Cells to Anti-Cancer Drug 5-Fluorouracil Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)62849-8  0.364
2008 Cheng AS, Shin VY, Wu K, Wong YP, Chong W, Siu JM, Ching AK, Go MY, Yu J, Chui Y, Cho CH, Fan D, Sung JJ, Leung WK. T2058 Both Transgenic and Host Cyclooxygenase-2 Expression Enhance Gastric Carcinogenesis Through Tumor Angiogenesis Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)62848-6  0.311
2008 Yu J, Wang S, Zeng Z, Wu J, Tian L, Leung WK, Zhang M, Hu P, Sung JJ. T2048 Nfkbia Polymorphisms and Their Associations with Susceptibility and Prognosis in Gastric Cancer Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)62838-3  0.34
2008 Li JJ, Ng EK, Ng YP, Yu J, Sung JJ, Ip NY, Leung WK. M1634 Overexpression of Retinoic Acid-Regulated Nuclear Matrix-Associated Protein (RAMP) Induces Cell Proliferation in Gastric Cancer: Potential Oncogenic Role of Ramp in Gastric Carcinogenesis Gastroenterology. 134: A-386. DOI: 10.1016/S0016-5085(08)61804-1  0.366
2008 Yu J, Cheng YY, Tao Q, Wong YP, Tian L, Jin H, Leung WK, Chan FK, Sung JJ. M1619 Methylated Protocadherin 10 Is Identified As a Target of Epigenetic Silencing and a Prognostic Predictor in Gastric Cancer Gastroenterology. 134: A-383. DOI: 10.1016/S0016-5085(08)61789-8  0.348
2008 Yu J, Tao Q, Cheng YY, Tian L, Cheung KF, Sung JJ. M1615 Aberrant Methylation of Dkk-3 in Gastric Cancer Associated with Poor Outcome Gastroenterology. 134: A-382-A-383. DOI: 10.1016/S0016-5085(08)61785-0  0.336
2008 Cheung K, Lam CN, Leung WK, Cheng AS, Ng EK, Chong W, Jin H, Sung JJ, Yu J. M1611 Epigenetic Characterization of a Novel Tumor Suppressor Gene, RNF180, in Gastric Cancer and Its Application in Noninvasive Cancer Detection Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)61781-3  0.38
2008 Yu J, Moriyama T, Ohuchida K, Cui L, Sato N, Nakamura M, Takahata S, Nagai E, Mizumoto K, Tanaka M. 430 Micro RNA (miR-17-5p) Is Overexpressed in Pancreatic Cancer, and Upregulation of miR-17-5p Enhanced Cancer Cell Proliferation and Invasion In Vitro Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)60292-9  0.305
2007 Ohuchida K, Mizumoto K, Miyasaka Y, Yu J, Cui L, Yamaguchi H, Toma H, Takahata S, Sato N, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. The Journal of Pathology. 213: 275-282. PMID 17940995 DOI: 10.1002/Path.2250  0.34
2007 Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. British Journal of Cancer. 97: 895-901. PMID 17848950 DOI: 10.1038/Sj.Bjc.6603968  0.411
2007 Chen Y, Lin MC, Wang H, Chan CY, Jiang L, Ngai SM, Yu J, He ML, Shaw PC, Yew DT, Sung JJ, Kung HF. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics. 7: 3097-104. PMID 17676662 DOI: 10.1002/Pmic.200700019  0.312
2007 Ohuchida K, Mizumoto K, Yu J, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiology, Biomarkers & Prevention. 16: 649-654. PMID 17416753 DOI: 10.1158/1055-9965.Epi-06-0157  0.335
2006 Ebert MPA, Yu J, Lordick F, Röcken C. Proteomics in gastrointestinal cancer. Annals of Oncology. 17. PMID 17018734 DOI: 10.1093/Annonc/Mdl269  0.359
2006 Leung WK, Man EP, Yu J, Go MY, To KF, Yamaoka Y, Cheng VY, Ng EK, Sung JJ. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3216-21. PMID 16707623 DOI: 10.1158/1078-0432.Ccr-05-2442  0.308
2006 Fu Y, Sung JJY, Wu K, Bai AHC, Chan MCW, Yu J, Fan D, Leung WK. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1. Cancer Letters. 243: 246-254. PMID 16412567 DOI: 10.1016/J.Canlet.2005.11.039  0.346
2006 Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology (Baltimore, Md.). 43: 134-43. PMID 16374840 DOI: 10.1002/Hep.20994  0.329
2005 Zhang JT, Wang MW, Zhu ZL, Huo XH, Chu JK, Cui DS, Qiao L, Yu J. Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients. World Journal of Gastroenterology. 11: 4918-22. PMID 16097073 DOI: 10.3748/Wjg.V11.I31.4918  0.381
2005 Fu YG, Sung JJ, Wu KC, Wu HP, Yu J, Chan M, Chan VY, Chan KK, Fan DM, Leung WK. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants. Cancer Letters. 224: 243-52. PMID 15914275 DOI: 10.1016/J.Canlet.2004.11.038  0.356
2005 Yu J, Leung WK, Chen J, Ebert MP, Malfertheiner P, Sung JJ. Expression of peroxisome proliferator-activated receptor delta in human gastric cancer and its response to specific COX-2 inhibitor. Cancer Letters. 223: 11-7. PMID 15890232 DOI: 10.1016/J.Canlet.2004.09.052  0.388
2005 Flesch FM, Yu JW, Lemmon MA, Burger KN. Membrane activity of the phospholipase C-delta1 pleckstrin homology (PH) domain. The Biochemical Journal. 389: 435-41. PMID 15755258 DOI: 10.1042/Bj20041721  0.509
2005 Yu J, Tang B, Leung WK, To K, Bai AHC, Zeng Z, Ma P, Go MYY, Hu P, Sung JJY. Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: Implications on chemoprevention World Journal of Gastroenterology. 11: 41-45. PMID 15609394 DOI: 10.3748/Wjg.V11.I1.41  0.306
2005 Chen J, Kähne T, Röcken C, Götze T, Yu J, Sung JJ, Chen M, Hu P, Malfertheiner P, Ebert MP. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. Journal of Proteome Research. 3: 1009-16. PMID 15473690 DOI: 10.1021/Pr049916L  0.363
2004 To KF, Chan MW, Leung WK, Ng EK, Yu J, Bai AH, Lo AW, Chu SH, Tong JH, Lo KW, Sung JJ, Chan FK. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. British Journal of Cancer. 91: 1335-41. PMID 15354212 DOI: 10.1038/Sj.Bjc.6602133  0.374
2004 Dove SK, Piper RC, McEwen RK, Yu JW, King MC, Hughes DC, Thuring J, Holmes AB, Cooke FT, Michell RH, Parker PJ, Lemmon MA. Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectors. The Embo Journal. 23: 1922-33. PMID 15103325 DOI: 10.1038/Sj.Emboj.7600203  0.529
2004 Yu JW, Mendrola JM, Audhya A, Singh S, Keleti D, DeWald DB, Murray D, Emr SD, Lemmon MA. Genome-wide analysis of membrane targeting by S. cerevisiae pleckstrin homology domains. Molecular Cell. 13: 677-88. PMID 15023338 DOI: 10.1016/S1097-2765(04)00083-8  0.514
2004 Leung WK, Bai AH, Chan VY, Yu J, Chan MW, To KF, Wu JR, Chan KK, Fu YG, Chan FK, Sung JJ. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. Gut. 53: 331-8. PMID 14960510 DOI: 10.1136/Gut.2003.021105  0.385
2004 Wild AC, Yu JW, Lemmon MA, Blumer KJ. The p21-activated protein kinase-related kinase Cla4 is a coincidence detector of signaling by Cdc42 and phosphatidylinositol 4-phosphate. The Journal of Biological Chemistry. 279: 17101-10. PMID 14766750 DOI: 10.1074/Jbc.M314035200  0.525
2004 Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD, Bai AHC, Sung JJY. Chemoprevention of gastric cancer by celecoxib in rats Gut. 53: 195-200. PMID 14724149 DOI: 10.1136/Gut.2003.021477  0.306
2003 Yu J, Leung WK, Ebert MP, Leong RW, Tse PC, Chan MW, Bai AH, To KF, Malfertheiner P, Sung JJ. Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. British Journal of Cancer. 88: 1560-5. PMID 12771922 DOI: 10.1038/Sj.Bjc.6600940  0.349
2003 Leung WK, Yu J, Bai AH, Chan MW, Chan KK, To KF, Chan FK, Ng EK, Chung SC, Sung JJ. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer. Molecular Carcinogenesis. 37: 91-7. PMID 12766908 DOI: 10.1002/Mc.10124  0.396
2003 Ebert MP, Yu J, Hoffmann J, Rocco A, Röcken C, Kahmann S, Müller O, Korc M, Sung JJ, Malfertheiner P. Loss of beta-catenin expression in metastatic gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 1708-14. PMID 12721245 DOI: 10.1200/Jco.2003.10.017  0.303
2003 Yu JW, Lemmon MA. Genome-wide analysis of signaling domain function. Current Opinion in Chemical Biology. 7: 103-9. PMID 12547434 DOI: 10.1016/S1367-5931(02)00008-X  0.522
2003 Yu J, Leung WK, Lee T, Tse PCH, To KF, Sung JJY. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma. International Journal of Oncology. 22: 1025-1031. DOI: 10.3892/Ijo.22.5.1025  0.395
2003 Leung WK, Bai AH, Chan VY, Yu J, Chan K, To K, Go MY, Wu K, Chan FK, Wu J, Sung JJ. Effect of PPARγ ligands on in vitro and in vivo growth of gastric cancer Gastroenterology. 124: A457. DOI: 10.1016/S0016-5085(03)82309-0  0.347
2003 Hu P, Yu J, Zeng ZR, Leung W, Sung J. Chemoprevention of gastric cancer by cyclooxygenase-2 inhibitor in rats Gastroenterology. 124: A293. DOI: 10.1016/S0016-5085(03)81477-4  0.343
2003 Yu J, Tang B, Leung WK, Hu p, To K, Bai A, Ma P, Go MY, Zeng Z, Sung JJ. Chemoprevention of Mnng-induced gastric cancer in rat by celecoxib is independent of COX-2 and PGE2 suppression Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)80575-9  0.354
2002 To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC, Sung JJ. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. International Journal of Cancer. Journal International Du Cancer. 102: 623-8. PMID 12448005 DOI: 10.1002/Ijc.10783  0.393
2002 Yu J, Leung WK, Go MY, Chan MC, To KF, Ng EK, Chan FK, Ling TK, Chung SC, Sung JJ. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut. 51: 480-4. PMID 12235067 DOI: 10.1136/Gut.51.4.480  0.34
2002 Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. The Journal of Pathology. 197: 582-8. PMID 12210076 DOI: 10.1002/Path.1147  0.4
2002 Yu J, Leung WK, Ebert MP, Ng EK, Go MY, Wang HB, Chung SC, Malfertheiner P, Sung JJ. Increased expression of survivin in gastric cancer patients and in first degree relatives. British Journal of Cancer. 87: 91-7. PMID 12085263 DOI: 10.1038/Sj.Bjc.6600421  0.403
2002 Miehlke S, Yu J, Ebert M, Szokodi D, Vieth M, Kuhlisch E, Buchcik R, Schimmin W, Wehrmann U, Malfertheiner P, Ehninger G, Bayerdörffer E, Stolte M. Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives. Digestive Diseases and Sciences. 47: 1248-1256. PMID 12064799 DOI: 10.1023/A:1015358127751  0.354
2002 Ebert MPA, Fei G, Kahmann S, Müller O, Yu J, Sung JJY, Malfertheiner P. Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer Carcinogenesis. 23: 87-91. PMID 11756228 DOI: 10.1093/Carcin/23.1.87  0.351
2001 To KF, Chan MWY, Leung WK, Yu J, Tong JHM, Lee TL, Chan FKL, Sung JJY. Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer Life Sciences. 70: 483-489. PMID 11798016 DOI: 10.1016/S0024-3205(01)01422-9  0.39
2001 Yu JW, Lemmon MA. All phox homology (PX) domains from Saccharomyces cerevisiae specifically recognize phosphatidylinositol 3-phosphate. The Journal of Biological Chemistry. 276: 44179-84. PMID 11557775 DOI: 10.1074/Jbc.M108811200  0.516
2001 Yu J, Leung WK, Ng EK, To KF, Ebert MP, Go MY, Chan WY, Chan FK, Chung SC, Malfertheiner P, Sung JJ. Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia. Alimentary Pharmacology & Therapeutics. 15: 1505-11. PMID 11552926 DOI: 10.1046/J.1365-2036.2001.01038.X  0.337
2001 Leung WK, Yu J, To KF, Go MYY, Ma PK, Chan FKL, Sung JJY. Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia. Alimentary Pharmacology & Therapeutics. 15: 1467-1472. PMID 11552920 DOI: 10.1046/J.1365-2036.2001.01057.X  0.322
2001 Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, Go MY, Chung SC, Sung JJ. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer. 91: 2294-301. PMID 11413518 DOI: 10.1002/1097-0142(20010615)91:12<2294::Aid-Cncr1261>3.0.Co;2-G  0.368
2001 Leung WK, Yu J, Go MY, To KF, Ma PK, Chan FK, Sung JJ. Changes in cell kinetics of gastric intestinal metaplasia before and after Helicobacter pylori eradication Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)83298-2  0.303
2001 Yu J, Leung WK, Ebert MPA, Ng EKW, Go MYY, Wang HB, Chung SCS, Malfertheiner P, Sung JJY. Expression of survivin and its correlation with cyclooxygenase-2 in gastric cancer Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)82461-4  0.372
2001 Leung WK, Yu J, Cheng ASI, Ebert MPA, Ng EKW, Chung SSC, Malfertheiner P, Sung JJY. Constitutive expression of peroxisome proliferator-activated receptor (PPAR) δ and γ in gastric carcinomas and non-neoplastic gastric mucosa Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)82458-4  0.325
2001 Ebert M, Gregel C, Fei G, Yu J, Leodolter A, Guenther T, Sung JJ, Malfertheiner P. Inverse correlation of LAR and beta-catenin expression in intestinal type gastric cancer Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)81466-7  0.341
2000 Ebert MPA, Yu J, Sung JJ, Malfertheiner P. Molecular alterations in gastric cancer: the role of Helicobacter pylori. European Journal of Gastroenterology & Hepatology. 12: 795-798. PMID 10929908 DOI: 10.1097/00042737-200012070-00013  0.352
2000 Ebert MPA, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, Stolte M, Bayerdörffer E, Malfertheiner P. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. British Journal of Cancer. 82: 1795-1800. PMID 10839293 DOI: 10.1054/Bjoc.1999.1107  0.371
2000 Yu J, Leung WK, Go MY, Chan FK, To KF, Sung JJ. Effects of H. pylori eradication on the expression of cyclin D2 and p27 in gastric intestinal metaplasia Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)85194-X  0.302
2000 Leung WK, Yu J, To KF, Ng EK, Ma PK, Lee T, Chung SS, Sung JJ. Concurrent hypermethylation of multiple tumor related genes in gastric cancer Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)82265-9  0.369
2000 Yu J, Ebert MPA, Miehlke S, Rost H, Lendeckel U, Leodolter A, Stolte M, Bayerdörffer E, Malfertheiner P. Alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first-degree relatives Gut. 46: 639-644. DOI: 10.1016/S0016-5085(00)82236-2  0.383
2000 Yu J, Leung WK, Ng EK, Chan WY, Go MY, Sung JJ. Differential expression of D-type cyclins and p27 in human gastric cancers Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)81566-8  0.349
1999 Yu J, Guo F, Ebert MPA, Malfertheiner P. Expression of inducible nitric oxide synthase in human gastric cancer. World Journal of Gastroenterology. 5: 430-431. PMID 11819482 DOI: 10.3748/Wjg.V5.I5.430  0.354
1994 Chen B, Yu J, Zeng Z, Chu W, Wong CYP, Cheng Y, Sung JJY, Hu P, Leung WK. Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression Oncology Reports. 20: 1093-1097. DOI: 10.3892/Or_00000114  0.384
Show low-probability matches.